Magnus Ahlqvist appointed new President and CEO of Securitas AB, as of March 2018

Since September 1, 2015, Magnus Ahlqvist is Divisional President of Securitas’ Security Services Europe and a member of Securitas’ Group Management. Magnus came to Securitas  from Motorola Mobility, a Google company before it was taken over by Lenovo, where he was Corporate Vice President of EMEA and India in Motorola. Before that, he worked 12 years for Sony Ericsson and Sony Mobile Communications. His assignments were, among others, President of Sony Mobile Communications in China for three years, Vice President and General Manager Spain & Portugal and Telefónica and General Manager in Canada. Magnus Ahlqvist, 43 years old, holds a Master of Science in Economics and Business Administration from the Stockholm School of Economics, and a leadership exam from Harvard Business School.   “Securitas is a wonderful company with very competent and engaged people. It is the leading security services company in the world. We have a winning strategy and we are leading the transformation of the security industry, from traditional on-site guarding to a considerably broader spectrum of advanced security solutions and electronic security. It is a great honor and I am very excited about working with all the great people in the Securitas team around the world during this new phase, when we will be driving an even stronger focus on new digital technology in security. Delivering the best engagement and service to our customers is of highest priority during this journey”, says Magnus Ahlqvist. Alf Göransson will continue his position as President and CEO of Securitas until March 2018. He will then during two years be an advisor to Securitas’ new President and CEO and will in this role among other things support in some customer relations activities, acquisition related matters and industry specific topics. Alf Göransson will leave Securitas’ Board of Directors at the same time as he resigns as President and CEO of Securitas. “In March next year, I have during 18 years been President and CEO of listed companies, and President and CEO of Securitas for 11 years. Now is the time to do something else in my career and in my life. It has been a fantastic privilege to lead this great company during 11 years, a company that today is leading the development of the security industry thanks to the strong culture and all the engaged employees”, says Alf Göransson. Marie Ehrling, Chairman of the Board of Securitas, says in a comment: -  For more than ten years as Securitas’ President and CEO, Alf Göransson has successfully developed Securitas. Today, the company is the leading company in the security industry, offering our customers complete security solutions based on both advanced electronic security and more traditional solutions. The transformation in the industry is happening fast and the next step will be to capture on the possibilities from new digital technology. This transformation has to be managed quickly and powerfully to maintain our position. It is very satisfying that Magnus Ahlqvist, President of Securitas’ European division, has accepted to take over the role as President and CEO as of March 2018. During his two years in the company, Magnus has showed strong leadership and great insights of the industry’s challenges, as well as a genuine sense of finding the best solutions for Securitas’ customers. With Magnus as the new President and CEO, we secure continuity in the company and a continued powerful implementation of Securitas’ strategy”, says Marie Ehrling. On August 14, 2017, Marie Ehrling, Alf Göransson and Magnus Ahlqvist will be available for comments at Securitas’ headquarter at Lindhagensplan 70, Stockholm, Sweden. This press release is also available at: www.securitas.com Information: Gisela Lindstrand, Senior Vice President Corporate Communications and Public Affairs, Securitas AB, mobile +46 70 287 8662, or email gisela.lindstrand@securitas.com Securitas is a global knowledge leader in security. We base our protective services on customer-specific needs through different combinations of on-site, mobile and remote guarding, electronic security, fire and safety and corporate risk management. Everywhere from small stores to airports, our 335 000 employees are making a difference. This is information that Securitas AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 20.00 (CET) on August 13, 2017.

THE MARKETING GROUP REPORTS FINANCIAL IMPACT OF THE DIVESTMENT OF THREE AGENCIES

London – 14 August 2017 - The Marketing Group PLC (“TMG” or the “Group”) announced on 10 August 2017 that, as part of the promised strategic review, it had agreed to divest three subsidiaries: Imagine Group, Wilkin Marketing and Skye Multimedia (the “Divestments”). Following finalisation of the terms of the Divestments and the agreement between the parties that, from a financial perspective, they will be effective as of 1 January 2017, the financial impact of the Divestments has led to the Group EBITDA in Q1 2017 being increased by €173k, from €125k to €298k. The Goodwill write off on the Divestments is €12,884,000.  The divested agencies will not contribute to the Q2 2017 results due to be reported on 15 August 2017. The Group had been conducting negotiations to divest the three companies for some time, but the results of these companies were originally included in the Group’s Q1 2017 results as there was no certainty at that time that the Divestments would be concluded. -ENDS- For more information, please contact Adam Graham, CEO Email: investorrelations@tmg-plc.com Media Jaime Carron Phone: 0207 1481606 Email: jaime.carron@tmg-plc.comInvestor relationsClaes Delin / Mikael WidellPhone: +46 703 11 9960E-mail: investorrelations@tmg-plc.com This information is information that The Marketing Group plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 7.00 am CET on 14 August 2017. The Marketing Group plc (“TMG”) in brief    TMG is building a global full-service marketing network that respects the individual cultures of each agency that joins. By providing a supportive platform for growth, and an agile management approach, TMG aims to provide a fresh alternative to the big holding companies: Independent Spirit - Global scale. Each company within the group provides specialist marketing services brought together, within complementary communities of practice, to form an international network that can address a global market. The central team supports its subsidiaries through a lean and nimble structure that can respond quickly to change and provide highly effective solutions for clients. The Marketing Group is listed on Nasdaq First North, Stockholm. www.tmg-plc.com. Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider.

Sweco to plan and design modernisation of Stockholm Central Station

Stockholm Central Station, spanning the area from Tegelbacken to Karlberg, is the busiest railway station in Sweden, with around 1,000 daily arrivals and departures. The station’s railway network and station environment must be modernised to meet future needs and improve accessibility for travellers. This includes everything from switchgears and new waiting bays and turntables for the trains to renovated and accessibility-adapted platforms. Due to the station’s size, location and significance for Sweden’s infrastructure, the project will be one of the most complex in the history of Swedish railways. Sweco’s  consultants will work in all of the project’s technical areas. ”We are pleased to be working closely with the Swedish Transport Administration to create the railway hub of the future for travellers and freight. With this project, we are providing our expertise, experience and commitment within a range of disciplines – from railways, environment and architecture to design, technical building services and project management,” says Åsa Bergman, President of Sweco Sweden. The project will be completed in stages to ensure that the station operates efficiently during the entire project period. Sweco is involved from project start through final construction, and will prepare systems documentation, conduct analyses including configuration programs, and produce tender documents for contractors. Sweco will also provide support to the Swedish Transport Administration as the real estate company Jernhusen is planning for an overbuild of the railway tracks. Work on the project will begin immediately and continues through 2022. Sweco estimates the project’s total order value to exceed SEK 300 million. In Stockholm, Sweco is already working with projects closely related to Stockholm Central, such as project Getingmidjan and the recently opened Stockholm City Line.

Humana expands in Finland

Humana AB has entered into an agreement to acquire all shares in Nordic Senior Services Oy (NSS Oy). The transfer will take place immediately and the operations of NSS Oy will be included in Arjessa, Humana’s Finnish subsidiary. Nordic Senior Services Oy currently operates seven elderly care units, one LSS unit and one social psychiatry unit. Business is conducted primarily in the central parts of Finland in Tampere and Vanta (Nyland) with about 135 employees and 155 customers. NSS Oy’s revenue for 2016 amounted to EUR 7.1 M and operating profit before goodwill amortisation was EUR 0.3 M. The acquisition means expansion of existing operations in Finland into new care segments while increasing Humana’s existing offer geographically. The acquisition will help Humana expand into two new important areas of care in the Finnish market, elderly care and LSS, while strengthening the company’s position as the leading Nordic provider of individual and family care services.   “The acquisition of Nordic Senior Services Oy is an important step in Humana’s ambition to become a complete care provider in Finland,” said Rasmus Nerman, CEO of Humana. “NSS Oy complements and extends our existing operations and strengthens our platform for further growth in Finland.” “I’m very pleased to welcome Nordic Senior Services Oy to Arjessa and Humana’s Finnish operations. I’m convinced that our shared values and care philosophy based on customer needs will create good development opportunities,” said Pasi Kohtala, CEO of Arjessa and head of Humana’s Finnish operations.  For more information, please contact:Ulf Bonnevier, CFO, +46 (0)70-164 73 17, ulf.bonnevier@humana.seCecilia Lannebo, Head of Investor Relations, +46 (0)72-220 82 77, cecilia.lannebo@humana.se

Sino Agro Food, Inc. Reports Q2 2017 Results

GUANGZHOU, China-- Sino Agro Food, Inc. (OTCQX: SIAF | OSE: SIAF-ME), a specialized investment company focused on protein food including seafood and cattle, announces results for the quarter ending June 30, 2017. Revenue  Results reflect the carve-out of aquaculture operations announced March 2, 2017. Income from Sino Agro’s 36.6% interest in the carved-out company, Tri-Way Industries Ltd. is reported as “share of income from unconsolidated equity investee.”  Revenue from the sale of goods from the former aquaculture business segment is no longer reported. Stripping out discontinued aquaculture revenue from Q2 2016, revenue from the sale of goods decreased USD 18.7M, or 28%, to USD 47.7M for the quarter ended June 30, 2017 year over year. Contrasted to Q1 2017, revenue decreased 17%. Business Segment Overview   Negative Comparisons (vs. Q2 2016) Integrated Cattle  (SJAP): The combined results of SJAP (including QZH) in Q2 2017 decreased in sales revenue by $18 million, and gross profit by $7.4 million Organic Fertilizer (HSA): Q2 2017 revenues decreased by $4.2M; gross profit decreased by $1.84M Plantation Division (JHST): Q2 2017’s revenues decreased by $4.7M; gross profit decreased by $2.7M Import and Export  -- beef only (Corporate Division): Q2 2017’s revenues decreased by $3.7M; gross profit decreased by $0.42M Project Development: Q2 2017’s revenues decreased by $19.3M; gross profit by $5.8M Positive Comparisons (vs. Q2 2016) Cattle Farm (MEIJI): Q2 2017’s revenues increased by $0.3 M; gross profits increased by 0$0.72M Import and Export  -- seafood only (Corporate Division): Q2 2017’s revenues increased by $2.3M; gross profits increased by $0.18M SIAF’s On-going Strategy  Integrated Cattle (SJAP) As reported last quarter, the Xining government engaged SJAP in discussions aimed to help the cattle and beef industry and promote economic development in the district, which boasts annual production of over four million head of cattle. SJAP was selected as the lead company to coordinate and carry out sweeping long-term regional plans. This also reflects the local government’s realization of the serious situation the cattle industry faces in the region, and is looking at various options to assist while waiting and working with the Central Government to produce a concrete revitalized plan to rebuild the industry. The Company’s plan in the interim is to: · restrict capital spending and to reserve its cash as much as possible to buy enough time while working through the interim planning process until such time as the Central and Local Government’s revitalization plan is adopted and implemented, · continue limiting operations of the adversely affected aspects of its business, · continue discussions with other operators in wholesaling, logistics, value added processing, general trading, etc. to negotiate an overall plan/solution in line with the government’s strategic plan, and, · supplant Australian beef imports with those from the USA that offer comparatively better value in price, quality, and selection As previously noted, decisions are to be governed by stricter discipline on return on capital employed (“ROCE”) in support of SJAP’s advised carve-out and spinoff plans. SJAP is fortunate to enjoy excellent working relationships with various government agencies. These private company/state agency relationships are perhaps more important in China than in western countries. For instance, SJAP has successfully created a local cooperative farmer network mutually beneficial for many years. Indeed, it is still viable; albeit, severely more challenging with the influx of highly competitive imported beef due to relaxed import restrictions. Government agencies recognize the mutual benefit of public/private cooperation. Support for the beef industry awaits a full assessment of forces to determine market equilibrium, before likely indicating a proper and effective stimulation to be supplied to local markets in the interest of all parties. Organic Fertilizer (HSA) Plans to adapt to changing market conditions at HSA have been formulated with the restriction of incurring any further capital expenditure until available through self-generated cash flow. Sales are anticipated to pick up from Q3 2017 after completion of the retrofit of its production plant. Profits are intended to increase from this quarter onward, eventually exceeding past performance once raw material is in adequate supply, targeting sometime during Q4 2017. Plantation  (JHST) There is no easy solution when disease sets in, except to replant the whole plantation with a new breed of disease-resistant HU plants that are currently available in China. However, the Company plans to restrict capital expenditure for the time being until such time as SIAF’s cash position becomes strong enough to consider future capital expenditure plans and direction. In the meantime, JHST will plan on growing seasonal cash crops that exhibit stable markets and steady prices to maintain its plantation operation for the remainder of this year until its able to consider various available options. The Company is confident in finding the appropriate solution. Import and Export  (Corporate) The company projects that by sometime in Q4 2017 imported beef from the U.S. should find its footing in the China market, providing a better guideline to importers overall and helping to determine an appropriate direction. In the interim, China is short in seafood supply with demand increasing each year. It is projected that China will become a negative importing country with a shortfall of over tens of millions of metric tons (“MMT”)/year within the next decade based on its current consumption of over 50 MMT/year. The current shortfall is running at some 6-7 MMT/year. In this respect, the locally grown seafood and imported seafood trade has strong potential to increase the Company’s sales revenue and profits, such that the plan is to increase import seafood trading starting in Q3 (to include frozen seafood), helping to offset some of the overall revenue decline Q2. Project Development Revenue and profit from this segment is expected to resume, returning to normal levels and above, once Tri-way secures its intended debt financing. In the interim, CA has been exploring opportunities in Southeast Asia (i.e. India, Vietnam, Indonesia, Malaysia and other countries) with the aim to turn into a global operator outside of China. Since this is at an early stage, the Company is not in a position to provide a timeframe or potential chance of success. However, the Company can report that it has made progress in this area, and intends to provide updates as they occur throughout the remainder of this year. Triway’s COSO Exercises Progress updates in this arena will continue over the coming weeks. Sequential Comparison, Continuing Operations, Sale of Goods: The Company achieved the following results, comparing the second quarter of 2017 to the first quarter of 2017: +-----------------------------------------+------+------+-----+|(USD M, except per share and margin data)|Q2 ‘17|Q1 ‘17|% |+-----------------------------------------+------+------+-----+|Revenue |47.7 |57.4 |(17) |+-----------------------------------------+------+------+-----+|Gross Profit |6.5 |10.0 |(35) |+-----------------------------------------+------+------+-----+|Gross Profit Margin |13.6% |17.4% |(3.8)|+-----------------------------------------+------+------+-----+|Earnings Per Diluted Share (FD) (USD) – |.03 |.36 |(94) ||from continuing and discontinued | | | ||operations | | | |+-----------------------------------------+------+------+-----+ Other Key Points   · Q2 2017 income from unconsolidated equity investment was USD 1.3M. This figure was based on a 23.8% equity interest in Tri-way, prior to registration and finalization of SIAF’s effective 36.6% interest, along with corresponding adjustments within the coming Q3 quarter,wherein someand there will bedebt re-paymentsby Tri-way to SIAFwill assist intoimprovingeSIAF’s cash flow starting from Q3quarter of2017. · As of June 30 2017, the Company had net working capital of USD 313.9M, a quarterly increase of USD 16.4M. · Stockholders’ equity increased in the quarter by USD 15.5M to USD 629.9M or USD 24.99 per share, based on the weighted average number of fully diluted outstanding shares in the quarter. CEO Commentary  Sino Agro Food’s Chairman and CEO Solomon Lee addressed the second quarter results and 2017 outlook: “The Company is confident that we will see a rebound in the remainder of 2017. On a more strategic front, in consultation with our partners and advisors, the aim is to prudently address the spectrum of external agricultural market conditions to facilitate our carve-out and spinoff exercises, some of which are well underway.” “The growth in demand for seafood in China is set to rise to 39kg per capita in 2020. Whereas the Chinese seafood industry is heavily challenged by sea pollution and overfishing of wild fish, Tri-way’s sustainable production environment produces healthy, safe and sustainable seafood all year round. Moreover, it produces premium quality seafood that can yield higher margins than competitors. We are encouraged by our business plan and the macro-trends that support our belief in this strategy. To further this strategy while minimizing risks and ensuring the long-term sustainability of its business model, Tri-way has decided to focus its near-term goals on securing financing to support the execution of this business plan before proceeding. “Tri-way continues to make meaningful progress toward securing this financing to develop its infrastructure and grow the business. Recent achievements include the granting of a credit facility of RMB 100 million with the Agricultural Bank of China (“ABC”), the world’s third largest bank based on reported assets, and being assigned the strongest credit rating, 5A-1, from Dun & Bradstreet, a reputable business services company headquartered in the U.S.A. These milestones confirm Tri-way’s credit worthiness, clean balance sheet, and its risk averse approach, all of which support our confidence in Tri-way’s ability to secure additional financing to complete the build out of Aquafarm 4 and to commence the construction of Aquafarm 5. “Moving onto our beef sales, we experienced a decline in sales this quarter due to a shift in market demand toward newer sources of imported beef. We adapted to the influx of Australian beef by importing it to the Shanghai Distribution Center, and in Xining for value added processing. Now, new imports offer a further competition, offering us the same opportunities to embrace, after a transitional period.  “Having previously identified the trend of imported beef, we have been transitioning toward premium domestic beef, while maintaining the farmer’s cooperative model, which promotes several missions. While we expect short-term headwinds related to increased competition from international beef farmers to impact sales, we are confident in our long-term strategy. We are fortunate to enjoy excellent working relationships with various government agencies, with which we are currently discussing new means to accomplish our mission, without SJAP having to continue businesses made unprofitable by the relaxation of import restrictions. These private company/state agency relationships hold greater significance in China than in western countries, and we are proud to have established a positive working relationship with the Xining Government in an effort to support our growth strategy. “During the quarter we also implemented several initiatives aimed at improving financial discipline across the business to support a sustainable and cost-efficient business model, such as concentrating on increasing free cash flow at Tri-way by optimizing operations at each aquafarm in terms of product mix and APRAS performance, and retrofitting HSA’s second production plant’s fertilizer processor to adapt to poultry. “I would like to thank our loyal shareholders as we implement these steps and work through this transition period toward building long-term value at the Company.” Q2 2017 Interim Report  For detailed segment operational performance and developments, please take the time to read our latest 10-Q filing, or refer to the Q2 2017 Interim Report  posted to the Company website at http://sinoagrofood.investorroom.com/download/Sino-Agro-Food_Q2-2017-Interim-Report.pdf  Earnings Call Information  The Company will host an earnings call on Thursday, August 31, 2017 at 10:00 AM EDT/4:00 PM CET to discuss quarterly financial results. Please submit questions by email to info@sinoagrofood.com. These will be organized and answered on the call. To listen to the conference call please use the following information: +-----------------------+--------------------------------+|SIAF Q2 2017 Results ||Call Information |+-----------------------+--------------------------------+|Date: August 31, 2017 |Time: 10:00 AM, EDT/16:00 PM CET|+-----------------------+--------------------------------+|Participant Dialing ||Instructions: |+-----------------------+--------------------------------+|SE:       +46 8 5059 63|UK:      +44 203 139 48 30 ||06 | |+-----------------------+--------------------------------+|NO:      +47 23 50 05 |CN:      +86 400 681 54 21 ||59 | |+-----------------------+--------------------------------+|US:      + 1 (866) 928 | ||-7517 | |+-----------------------+--------------------------------+|Conference ||Pincode 75442190#   || The earnings call will ||also be available over ||the web.To access, ||click the following ||link:   Sino Agro Q2 ||2017 Earnings Call  ||   |+-----------------------+--------------------------------+

Positive judgement on the international patent application for Temodex

Double Bond Pharmaceutical AB has now received a positive judgement on a comprehensive review of the international patent application for Temodex – the novel therapy against brain cancer. The European Patent Office (EPO) was selected as the Examining Authority to get a critical and detailed analysis on how the application will be reviewed and evaluated by EPO in the European phase. The international patent application (PCT) for Temodex was submitted by Double Bond Pharmaceutical on April 28th 2017. "It is extremely important for Double Bond Pharmaceutical that EPO considers our patent application to meet patentability requirements", - commented CEO Igor Lokot. "This message is fully in line with our plan and is a very important milestone in both short- and long-term development of Temodex." About TemodexTemodex, which is a locally acting formulation of temozolomide, was developed by RI PCP in Minsk, Belarus, and is registered for marketing within Belarus since 2014 as the first-line treatment of glioblastoma. Temodex was acquired by DBP in autumn 2015 and is now being prepared to pass through all the tests and trials required for registration within the EU and globally. Find out more here . About the company: www.doublebp.com This information is information that Double Bond Pharmaceutical International AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14th of August 2017. 

WntResearch announces that the last patient has been treated in a Phase 1b study with the drug candidate Foxy-5

Preliminary results from the dose-finding part of the study showed that Foxy-5 has a favorable safety profile and provides clear signals of biological effect. Based on these positive results, a dose level was selected for evaluation in a further few patients, who have now completed their treatment. The same dose level will be evaluated in an upcoming Phase 2 study. "The completion of the Phase 1b study with Foxy-5 is an important milestone for WntResearch. With the completed clinical study as a basis, we can now proceed and plan for the continued development of our unique drug candidate against tumor spread," says Henrik Lawaetz, CEO of WntResearch AB. The Phase 1b study was performed on patients with cancer in the colon, prostate or breast, for a three-week treatment period. In consultation with their physician, some patients chose to continue treatment for a few weeks after the formal study period ended. Foxy-5 showed a continued favorable safety profile in these patients. "The successful completion of the Phase 1b study, and the recently announced positive preliminary results from a retrospective study, provide an excellent basis for optimizing the Phase 2 study design," commented Henrik Lawaetz, CEO of WntResearch AB. For further information contact: Henrik Lawaetz, CEOE-mail: hl@wntresearch.comTelephone: +46 72 702 4694 This information is information that WntResearch AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on August 14, 2017. About WntResearch WntResearch is developing a new type of cancer treatment based on pioneering research, which shows that the endogenous protein Wnt-5a plays a crucial role for tumour cells’ ability to relocate and spread in the body. Most patients that die of cancer do so not due to the primary tumour, but due to metastases. The need for a specific treatment to counteract metastasis is therefore in high demand. WntResearch’s most advanced drug candidate Foxy-5 has in preclinical tests been shown to reduce tumour cells’ mobility and thereby counteract the occurrence of metastases. The results from a completed phase 1 study show a favourable safety and pharmacokinetic profile, as well as early indications of biological activity. A phase 1b study is currently ongoing in patients with cancer of the colon, prostate and breast. WntResearch is a public company listed at AktieTorget in Stockholm, Sweden. For further information: www.wntresearch.com

SenzaGen secures patent protection for its GARDskin™ test in Europe

The recently granted European patent covers the analytical methods and genetic signatures that form the foundation of SenzaGen´s proprietary GARDskin™ technology. The patent is valid until October 2031. "This affirmation from the European Patent Office of the merits of our technology is an important milestone in SenzaGen's strategic plan to establish our unique GARDskin™ test as a new global standard for the industry. Robust patent protection in Europe for GARDskin™ further strengthens our company's commercial potential and makes us even more attractive to international distribution partners," says SenzaGen's CEO, Anki Malmborg Hager. The announcement from the European Patent Office relates to European Patent No. 2,633077 B, entitled: "Analytical methods and arrays for use in the identification of agents inducing sensitization in human skin". Corresponding patent applications are currently being processed by the patent authorities in Brazil, Canada, China, Hong Kong, India, South Korea and the United States. For more information please contact:Anki Malmborg Hager, CEO, SenzaGen ABEmail: anki.malmborg.hager@senzagen.comTelephone: +46 768 284822 About GARD™GARD is a group of tests for assessing chemical skin sensitizers. The tests make use of genetic biomarkers for more than 200 genes which cover the entire immune reaction and are relevant to predicting the risk of hypersensitivity. The tests have up to 90% reliability. This compares with the current predominant test method, experiments on mice, which has an accuracy of 70-75%. SenzaGen's tests are also capable of measuring the potency of a substance's allergenic properties. Consequently, GARD tests provide a much more comprehensive basis for determining whether a substance should be classified as an allergen than current testing methods. About SenzaGenSenzaGen makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals we come into contact with in our daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes. The company's patented tests are the most reliable on the market and provide more information than traditional evaluation methods. We ourselves sell the tests in Sweden and the USA, and we sell through partners in several other countries. Over the next few years the company will expand geographically, make alliances with more distribution partners and launch further unique tests. SenzaGen has its headquarters in Lund in Sweden and a subsidiary in San Francisco, USA. For more information visit www.senzagen.com 

Nexam Chemical presents the second quarter 2017 on August 18 at 11:00 CET

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Anders Spetz, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https://tv.streamfabriken.com/nexam-chemicals-q2-2017  If you do not intend to ask questions at the end of the presentation, please both listen and see the presentation via audio webcast for increased quality. Phone number for the conference: Sweden: +46 8 5664 2509 UK: +44 20 3008 9807  No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start. In connection with the conference, it will be possible to ask questions directly or via e-mail. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com ___________________________________________________________________________ About Nexam Chemical Nexam Chemical develops technology and products that make it possible to significantly improve the production process and properties of most types of plastics in a cost-effective manner and with retained production technology. The improved properties include strength, toughness, temperature and chemical resistance as well as service life. The improvements in properties that can be achieved by using Nexam Chemical's technology make it possible to replace metals and other heavier or more expensive materials with plastics in a number of applications. In applications where plastic is already used, Nexam Chemicals products can improve the manufacturing process, reducing material use and enable more environmental friendly alternatives. Example of commercial applications: pipe manufacturing, foam production and high-performance plastics. More information about the business will be found on www.nexamchemical.com . The company´s Certified Adviser is FNCA Sweden AB.

AXACTOR Q2-2017 REPORT - RECORD STRONG OPERATIONAL PERFORMANCE

Oslo, 14 August 2017, Highlites * Strong operational performance and significant margin expansion for the quarter. * Continued to grow the business through new NPL acquisitions and contracts * Growth also fueled by additional funding facilities from the banks in addition to private placement * Gross Revenue of EUR 26.9 million (7.8) - up 341% vs Q2 2016 * EBITDA of EUR 6.1 million (-3.4)     - up 179% vs Q2 2016 * Cash EBITDA of EUR 9.4 million (-2.1)   - up 447% vs Q2 2016 * Net result positive with 4.6 million (-2.8) - up 164% vs Q2 2016 * ERC at end of Q2 EUR 511 million (126) -  up 305% vs Q2 2016 * Settlement with former IGE Board members increased Q2 revenue and EBITDA by EUR 2 million. Axactor shows strong operating performance during the second quarter of 2017 and continues to grow the business through acquisitions of NPL (none performing loan) portfolios and signing of new 3PC  (third party collection) contracts. To fuel the growth the company has secured additional funding facilities from the banks in addition to the private placement which was successfully completed during the quarter. The strong performance resulted in an EBITDA of EUR 6.1 million and an operating margin of 26.3%. The gross collection of EUR 26.9 million was in line with company expectations. The Group posted a record-high quarterly cash EBITDA of EUR 9.4 million, an increase of EUR 11.5 million compared to Q1 2016 and an increase of EUR 5.8 million compared to the previous quarter.  A settlement with the former IGE Board members contributed with a positive one-time effect of approx.EUR 2 million to revenue and EBITDA as Axactor in June received EUR 1.6 million cash and 0.4 million in none cash compensation. The major contributor to the enhanced operational result is the Bank Norwegian portfolio where the portfolio shows performance well ahead of the initial investment case. Additionally, 3PC revenue was up by 17 % compared to previous quarter. These two elements, combined with the mentioned settlement, resulted in a significant margin expansion for the quarter. "Second quarter was a good quarter for Axactor, where we achieved a good performance in our operations and continued the growth of the company as planned. The Bank Norwegian portfolio we acquired at the very end of Q1 has performed well in Q2, and significantly contributed to the EBITDA uplift we now are seeing", says Endre Rangnes, CEO in Axactor. During the quarter Axactor acquired its first portfolio in Germany and the first secured portfolio in Spain. In total Axactor invested EUR 54 million across 6 portfolios which increased ERC at the end of the quarter to EUR 515 million. Axactor increased the borrowing facilities in Norway and Italy by a total of EUR 72 million during the quarter, bringing the total borrowing facilities earmarked for investments up to EUR 175 million. In July, DNB and Nordea further made a 5th tranche of EUR 40 million available, bringing total borrowing facilities for investments to EUR 215 million. The market for purchases of NPL portfolios remains buoyant, with Spain and the Nordics being the most active markets. New contracts within the 3PC segment are showing positive developments, particularly in Spain, where a total of 7 new contracts with a combined annual value of EUR 8 million have been announced during the quarter. "We continue to focus on profitable growth within Axactor's current markets. We are staying true to our strategy and have reached several important milestones ahead of time. It is inspiring for the whole Axactor team to see that our strategy is bearing fruits", says Endre Rangnes. For further information, please see the presentation and the Q2 2017 report attached.  The documents are also available on the Company's website: www.axactor.com For additional information, please contact: Endre Rangnes, CEO Axactor Mobile phone: +47 4822 1111 Email: endre.rangnes@axactor.com or Geir Johansen, CFO & Investor Relations, Axactor Mobile phone: +47 4771 0451 Email: geir.johansen@axactor.com www.axactor.com About Axactor Axactor Group specializes in both Debt Collection and Debt Purchasing across several countries, with operations in Italy, Germany, Norway, Sweden and Spain. The company has a Nordic base and an ambitious Pan-European growth strategy, which targets the market for non-performing loans (NPL) in Europe. This market is estimated to be about 1,500 billion euros across Europe providing significant opportunities for Axactor's future expansion. Axactor has approximately 888 employees. 

Dome Energy gives operational update; Drilling program in Illinois Basin starts

Dome Energy AB.  (herein after “Dome” and/or “the Company”) announces the commencement of a four well drilling program on leases secured earlier this year. Dome has partnered with several vendors with extensive knowledge in the Illinois Basin and expect a safe and successful drilling program. The four wells are targeting the Mississippian Carbonate section at a depth of 4,100 feet. The initial drilling program will delineate the recently purchased acreage in which all wells were fracture stimulated in the Mississippian section. After extensive geologic and engineering review of the existing assets and current technologies, Dome believes that each well will recover 60 MBO. After the drilling and completion of this initial drilling program, the Company will aim to prove up seven additional PUD locations (net three locations). Permits have been submitted to the Indiana Department of Natural Resources. Drilling of the Matz 11-1, 11-2, Walgrove 11-4, and Glaze Estate 11-10 will commence within 30 days. Paul Morch, CEO: “We are excited to commence our drilling program. This is the first hydro fracturing program we will enter, and the results of these wells can prove up to 27 continuous drilling locations on our acreage. The well economics is expected to be similar to our Orange wells, with each well producing more than 50,000 barrels in its lifetime, and drilling costs at around $500,000 per well. We are reviewing acquisition of additional acreage in the area, but want to see the drilling results before making any decisions. We will continuously update the market with info throughout the drilling program.” For further information, please contact:Paul MorchPhone: +1 713 385 4104E-mail: pm@domeenergy.comThis information is the kind of information that Dome Energy AB (publ) is obliged to publicize according to EU Market Abuse Regulations (MAR). The information was publicized, by the above contact person August 14, 2017, 09.45 CET.About Dome EnergyDome Energy AB. is an independent Oil & Gas Company publicly traded on the Nasdaq First North exchange in Sweden (Ticker: DOME ). Mangold Fondkommission AB, phone: +46 8 503 01 550, is the Company’s Certified Adviser. Headquartered in Houston, Texas, the Company’s focus is on the development and production of existing onshore Oil & Gas reserves in the United States. For more information visit www.domeenergy.com.

Axactor completes NOK 598 million private placement to finance participation in co-investment partnership and further growth

Oslo, 14 August 2017 - Axactor AB (publ) ("Axactor" or the "Company") has today completed a private placement with gross proceeds of NOK 598 million (the "Private Placement") in order to fund Axactor's equity investment in the portfolio investment company to be established together with Geveran Trading Co. Limited, a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family ("Geveran"), and further portfolio acquisitions. Axactor has through the Private Placement placed 240 million new shares (the "Offer Shares") for gross proceeds of NOK 598 million. The subscription price per Offer Share (the "Offer Price") was set at NOK 2.49, equal to the close price on 11 August 2017. The Private Placement was directed at Geveran and existing shareholders of Axactor. Following completion of the Private Placement, Geveran will own 151 million shares, representing 9.96 per cent of the outstanding shares. Management did not participate in the Private Placement due to certain restrictions under Swedish law. DNB Markets, a part of DNB Bank ASA acted as manager for the Private Placement (the "Manager"). Notification of allotment will be sent to the applicants by the Manager on or about 14 August 2016. In order to provide for prompt registration of the share capital increase, the Company and the Manager have entered into an agreement related to pre-funding of the payment for the Offer Shares allocated in the Private Placement, such agreement regulating inter alia certain rights and obligations of the Company and the Manager related to the pre-funding. The Private Placement is divided into i) a tranche 1 consisting of 75,610,500 Offer Shares (the "Tranche 1"), and ii) a tranche 2 consisting of 164,389,500 Offer Shares (the "Tranche 2"). The Tranche 1 shares are tradable once the share capital has been registered in the Swedish Companies Registry and announced by the Company, expected on or about 17 August 2017. The Offer Shares in Tranche 1 will be settled through a delivery versus payment transaction expected on or about 18 August 2017. The Offer Shares in Tranche 2 will be settled through a delivery versus payment transaction following the registration of the share capital in the Swedish Companies Registry and approval of a listing prospectus by the Swedish Financial Supervisory Authority. The settlement of Tranche 2 is expected in the second half of September 2017 and the Offer Shares in Tranche 2 will be tradable from the same time. The Offer Shares to be issued in connection with the Private Placement will be issued based on the board authorisation granted by the Company's annual general meeting on 31 May 2017. Following the registration of the new share capital in Tranche 1 and Tranche 2, the Company will have 1,516,488,769 shares outstanding and a total share capital of EUR 79,312,362.62. As a consequence of the private placement structure, the shareholders' preferential rights were deviated from. After due considerations, the Board of Directors of the Company is of the opinion that the Private Placement is in the best interest of the Company and its shareholders. The Board of Directors has taken into consideration, among other things, the fact that the Private Placement was required in order to agree the letter of intent regarding the establishment of the portfolio investment company with Geveran and that the Private Placement will enable Axactor to further strengthen its shareholder base with Geveran, a strategic and high quality investor with long experience within the sector, and that the Offer Price is equal to the market price of the shares. The Board of Directors is of the opinion that there are sufficient reasons to deviate from the shareholders' pre-emption right to subscribe for the new shares. As described in the Company's stock exchange notice regarding the establishment of the investment portfolio company with Geveran, Axactor has resolved to grant 130,000,000 American style warrants in Axactor to Geveran in relation to the establishment of the portfolio investment company. Due to the changes in the ownership structure following completion of the Private Placement, Geveran has requested that the Board of Directors call for an extraordinary general meeting in order for Geveran to have one representative in the Board of Directors. The nomination committee has been notified and will start its work to evaluate changes to the new Board of Directors. The Board of Directors will call for an extraordinary general meeting as soon as the nomination committee has made a proposal. For additional information, please contact: Endre Rangnes, CEO Axactor Mobile phone: +47 4822 1111 Email: endre.rangnes@axactor.com or Geir Johansen, CFO & Investor Relations, Axactor Mobile phone: +47 4771 0451 Email: geir.johansen@axactor.com www.axactor.com About Axactor Axactor Group specializes in both Debt Collection and Debt Purchasing across several countries, with operations in Italy, Germany, Norway, Sweden and Spain. The company has a Nordic base and an ambitious Pan-European growth strategy, which targets the market for non-performing loans (NPL) in Europe. This market is estimated to be about 1,500 billion euros across Europe providing significant opportunities for Axactor's future expansion. Axactor has approximately 888 employees.

Axactor and Geveran enter into co-investment partnership securing EUR 300 million in investment capacity

Oslo, 14 August 2017 - Axactor AB (publ) ("Axactor") and Geveran Trading Co. Limited, a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family ("Geveran"), have signed a letter of intent regarding the establishment of a jointly owned portfolio investment company (the "Portfolio Investment Company"). Axactor and Geveran will both invest EUR 30 million of equity and hold a 50 per cent ownership each. In addition, Geveran will provide a subordinated debt facility of up to EUR 120 million. The Portfolio Investment Company will in addition seek bank financing. The targeted investment capacity of the Portfolio Investment Company will be around EUR 300 million. The Portfolio Investment Company will focus on larger portfolios above EUR 30 million in Capex and have a first right of refusal on such portfolios. The Portfolio Investment Company will invest in new portfolios for a period of 24 months after which the Portfolio Investment Company will continue to manage the portfolios acquired up until then. Axactor will continue to acquire commercially attractive portfolios below the EUR 30 million threshold on its own. The Portfolio Investment Company may acquire portfolios below EURm 30 that Axactor does not acquire. Axactor will have an exclusive service agreement with the Portfolio Investment Company under which Axactor will manage and collect the claims owned by the Portfolio Investment Company. Axactor will charge the Portfolio Investment Company a 5 per cent mark-up on debt collection services. The Portfolio Investment Company will be capitalised with EUR 60 million of equity, a subordinated debt facility with Geveran (or one of its affiliates) of EUR 120 million and bank financing of around EUR 120 million. The subordinated debt facility will have a 5 year tenor with an interest margin of 650 bps over EURIBOR. Consequently, the Portfolio Investment Company will have a target leverage of up to 80 per cent loan-to-value securing a highly competitive capital structure with attractive equity returns. "We are very pleased to have Geveran as our co-investment partner. They have long experience in the sector and significant capital available. This partnership enables Axactor to substantially increase our total investment capacity, and is an important strategic milestone for the company. We can pursue larger acquisitions while optimising the cost of capital and managing the risk of larger purchases. The service agreement between Axactor and the Portfolio Investment Company will secure immediate and attractive cash flow generation to Axactor, while the capital structure of the Portfolio Investment Company will secure attractive equity returns to the Axactor shareholders", says Endre Rangnes, CEO of Axactor. Axactor and Geveran will each have 50 per cent of the representatives of the Board of Directors of the Portfolio Investment Company. Axactor will prepare and present the business case for portfolio purchases within scope to the Board of Directors of the Portfolio Investment Company. Each party shall have veto right regarding portfolio purchases. The establishment of the Portfolio Investment Company is subject to the parties entering into final agreements. The target is for the Portfolio Investment Company to be operational from early Q4 2017. Related to the establishment of the Portfolio Investment Company, Axactor has resolved to grant 130,000,000 American style warrants in Axactor to Geveran with an exercise price of NOK 3.25. The warrants will only be exercisable if the Portfolio Investment Company is established, and will expire 2 years thereafter. The warrants are subject to customary recalculation provisions following certain capital events. Endre Rangnes, CEO of Axactor, Oddgeir Hansen, Chief Operating Officer of Axactor and Johnny Tsolis, Executive Vice President, Strategy & Projects of Axactor, have agreed to enter into a 2 year lock-up undertaking in relation to the shares currently owned by them. DNB Markets, a part of DNB Bank ASA, acted as financial adviser for Axactor relating to the Portfolio Investment Company. For additional information, please contact: Endre Rangnes, CEO Axactor Mobile phone: +47 4822 1111 Email: endre.rangnes@axactor.com or Geir Johansen, CFO & Investor Relations, Axactor Mobile phone: +47 4771 0451 Email: geir.johansen@axactor.com www.axactor.com About Axactor Axactor Group specializes in both Debt Collection and Debt Purchasing across several countries, with operations in Italy, Germany, Norway, Sweden and Spain. The company has a Nordic base and an ambitious Pan-European growth strategy, which targets the market for non-performing loans (NPL) in Europe. This market is estimated to be about 1,500 billion euros across Europe providing significant opportunities for Axactor's future expansion. Axactor has approximately 888 employees.

Autoliv declares dividend

The dividend will be payable on Thursday, December 7, 2017 to Autoliv stockholders of record on the close of business on Wednesday, November 22. The ex-date will be Tuesday, November 21 for holders of common stock listed on the New York Stock Exchange (NYSE) as well as holders of Swedish Depository Receipts (SDRs) listed on Nasdaq Stockholm. Inquiries: Thomas Jönsson, Vice President Corporate Communications, Tel: +46 8 58 72 06 27 This information is information that Autoliv, Inc. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out above, at 11.00 CET on August 14, 2017. About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 80 facilities with 70,000 employees in 27 countries. In addition, the Company has 22 technical centers in ten countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2016 amounted to about US $10.1 billion. The Company's shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com. Safe Harbor Statement This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any such statements in light of new information or future events, except as required by law.

Settling with former development partner.

In 2016, Brighter announced the outcome of the other two processes. Read more here: Okt 12, 2016 | Brighter wins arbitration case against former development partner.  June 8, 2016 | Brighter ensures all the rights in the patent dispute - Hotswap waives all claims to ownership.  About Brighter AB (publ) Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms. The Company's shares are listed on NASDAQOMX First North/BRIG . Visit our website and subscribe to press releases: www.brighter.se  Follow us on:    www.introduce.se Certified Adviser Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com. For further information, please contact: Henrik Norström, COOTelephone: +46 733 Truls Sjöstedt, CEOTelephone : +46 70940 30 45Email: 73 46 00Email:henrik.norstrom@brighter.se truls.sjostedt@brighter.se This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 11:00 CET on August 14, 2017.

Several new publications with CELLINKs technology

CELLINKs products has recently been featured in several new publications by customers and collaborators. The publications show the continues progress in the field of Bioprinting as well as how CELLINKs product range helps accelerate the research in the field. One review focuses on developments in the field of bioprinting for musculoskeletal tissue engineering, along with discussion on the various approaches for bone, cartilage, and connective tissue fabrication. Title of review: 3D bioprinting for musculoskeletal applications. In another study PDX Cells (Patient-derived Xeongrafts) were mixed with partially cross-linked hydrogel and printed with the INKREDIBLE 3D-Bioprinter. Title of study: Combination of CDODA-Me, a glycyrrhetinic acid derivative, and Erlotinib overcomes chemo-resistance in NSCLC PDX spheroids and 3D bio-printed cells, and New Frontiers in Biomaterials. In New Frontiers in Biomaterials new advancements in the field of biomaterials for regenerative medicine are discussed. The article concludes that with recent advancements previously unattainable results within skin, nerve, muscle, and specialized tissue are now within reach. “It’s exciting to see more publications where our technology has played a key part, and as time passes on we will see more and more publications during the next 12-months. Publications helps verifying the standard of our technology and is important for our long term-success and growth.” - Erik Gatenholm, CEO, CELLINK. Read more: http://www.oralmaxsurgery.theclinics.com/article/S1042-3699(16)30076-0/fulltext  https://www.futuremedicine.com/doi/pdf/10.2217/3dp-2017-0004  http://cancerres.aacrjournals.org/content/77/13_Supplement/2072.short  For further information, please contact: Erik Gatenholm, CEO                                     Gusten Danielsson, CFO Phone: +46 73 267 00 00                             Phone: +46 70 991 86 04 E-mail: eg@cellink.com                                E-mail: gd@cellink.com About CELLINK CELLINK has created one of the world's first universal Bioinks, today used by many of the world's most well-reputed research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in so-called 3D-Bioprinters. CELLINK's universal Bioink shows excellent results and can be used in both CELLINK's proprietary 3D Bioprinters and in 3D Bioprinters developed by other operators. Mangold Fondkommission AB, tel: +46 (0) 8 5030 1550, is the Company's Certified Adviser.

The Swedish Securities Council chooses not to rule on Haldex’ submission before the extraordinary general meeting

On August 2, Haldex has applied to the Swedish Securities Council to reject an extension of the acceptance period of Knorr-Bremse's public offer for Haldex. Knorr-Bremse has announced that it intends to apply for an extension of the acceptance period until February 2018. Haldex is of the opinion that the target company should also be able to submit an application as the company is being harmed by a lengthy bid process. The Swedish Securities Council has today decided not to process the Haldex submission but to wait for an application from Knorr-Bremse. “The problem with today’s decision is in reality that the uncertainty continues which has a negative impact on Haldex and you can of course have views on the fact that the Swedish Securities Council actively avoids to create clarity when given the opportunity to do so. At the same time we are not surprised on the basis on the views expressed by representatives of the Swedish Securities Council in this matter in media. But for the Board of Directors that has a responsibility to act in the best interest of the company, it was a question that had to be tested.” “In its essence, it does not change anything. The Board is committed not to recommend an extension and looks forward to the extraordinary general meeting later this week where the shareholders will be given the opportunity to be heard.”, says Jörgen Durban, chairman of the Board of Directors.

NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 22 NOVEMBER 2017

Oslo, Norway, 14 August 2017 Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics forhaematological cancers, will host a capital markets day on 22 November 2017. The date has been changed from 27 September due to availability of speakers. The capital markets day presentations will follow immediately after the third quarter 2017 earnings presentation. Members of the company’s executive management team and external speakers will share insights on Nordic Nanovector's strategy and market opportunities. Venue: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Date: 22 November 2017 Time: 10:00 – 13:30 CET, followed by lunch. Registration from 09:30 CET. Registration: e-mail to ir@nordicnanovector.com by 31 October 2017 The presentations will be recorded as a webcast and will be available at www.nordicnanovector.com in the section Investor Relations the same day. For further information, please contact: IR enquiriesTone Kvåle, Chief Financial OfficerCell: +47 91 51 95 76Email: ir@nordicnanovector.com Media EnquiriesMark Swallow/David Dible (Citigate Dewe Rogerson)Tel: +44 207 282 2948/+44 207 282 2949Email: mark.swallow@citigatedr.co.uk / david.dible@citigatedr.co.uk About Nordic Nanovector:Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37 -targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. The Company aims to rapidly develop Betalutin®, alone and in combination with other therapies, for the treatment of major types of NHL, targeting first regulatory submission in relapsed/refractory follicular lymphoma in 1H 2019. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. The Company is also advancing a pipeline of ARCs and other immunotherapies for multiple cancer indications. Further information about the Company can be found at www.nordicnanovector.com

Reminder: Join Asetek Q2 2017 Results webcast on Wednesday, 16 August

Asetek will release its financial results for the second quarter 2017 on Wednesday, 16 August at 7:00 AM CEST. This is followed by a presentation by CEO André Sloth Eriksen and CFO Peter Dam Madsen at 8:30 AM CEST. Asetek invites investors, analysts and media to join the presentation. The presentation is expected to last one hour, including Q&A, and can be followed through live webcast or by conference call. Conference call – audio onlyPlease dial in 5-10 minutes prior using the phone numbers and confirmation code below: +-----------------------------------+-------------------+|Copenhagen, Denmark: |+4532 71 16 59 |+-----------------------------------+-------------------+|Oslo, Norway: |+472350 0486 |+-----------------------------------+-------------------+|Stockholm, Sweden: |+46(0)8 5033 6538 |+-----------------------------------+-------------------+|Frankfurt, Germany: |+49(0)69 2222 10629|+-----------------------------------+-------------------+|London, United Kingdom: |+44(0)20 3427 1916 |+-----------------------------------+-------------------+|Paris, France: |+33(0)1 76 77 22 29|+-----------------------------------+-------------------+|New York, United States of America:|+1646 254 3362 |+-----------------------------------+-------------------+|Confirmation code: 5557928 |+-----------------------------------+-------------------+ Webcast – audio and slide presentationPlease join the Q2 2017 Results webcast by clicking here . The Second Quarter Report and presentation will also be made available on www.asetek.com and www.newsweb.no, as well as through news agencies. A recorded version of the presentation will be made available on www.asetek.com approximately two hours after the broadcast has concluded. For further information, please contact:Peter Dam MadsenChief Financial OfficerMobile: +45 2080 7200 investor.relations@asetek.com

DNB ASA - Share buy-back programme finalised

DNB ASA has finalised its share buy-back programme announced on 12 July 2017. A total of 5.4 million shares were repurchased in the open market, whereas a total of 2.7 million shares will be redeemed from the state of Norway, so that its ownership interest in DNB ASA of 34 per cent will remain unaffected following completion of the buy-back programme. The weighted average purchase/redemption price for the 5.4 million shares is NOK 152.75 and with this DNB ASA will return approximately NOK 821 million to shareholders. The 8.1 million shares will be cancelled subject to approval by the annual general meeting in 2018, whereby the number of DNB ASA’s registered shares will be reduced by 0.5 per cent from today's 1 628 798 861. For further information, please contact: Investor contacts:Rune Helland, head of Investor Relations, tel. ( 47) 23 26 84 00 / ( 47) 977 13 250Amra Koluder, SVP Investor Relations, tel. ( 47) 23 26 84 08 / ( 47) 977 35 378 Background information about the finalised programme DNB ASA has decided to initiate a share buy-back programme comprising up to 0.5 per cent of its registered shares, representing a total of 8.1 million shares. The buy-back programme will be carried out on the basis of the authorization given by DNB ASA’s annual general meeting on 25 April 2017, where it was approved that DNB ASA may repurchase shares up to a maximum of 1.5 per cent of its registered shares. DNB ASA may at a later stage decide to initiate further share buy-back programmes, up to the maximum limit approved by the annual general meeting. Up to 5.4 million of the shares comprised by the buy-back programme will be repurchased in the open market. The remaining shares will be redeemed from the state of Norway through the Ministry of Trade, Industry and Fisheries, according to an agreement between DNB ASA and the state of Norway and subject to approval from DNB ASA’s annual general meeting in 2018. According to the agreement, the state of Norway shall redeem shares on a proportionate basis so that its current ownership interest in DNB ASA of 34 per cent remains unaffected following completion of the buy-back programme. DNB ASA will seek approval from the annual general meeting in 2018 for cancellation of the repurchased shares and a corresponding redemption of the proportionate number of shares owned by the state of Norway. The redemption of the shares owned by the state of Norway shall be made against a payment which shall correspond to an average volume weighted price of DNB ASA’s repurchase of shares in the open market as a part of the buy-back programme, including an interest compensation and an agreed adjustment for dividend paid on the redemption shares in the buy-back period (if any). Subject to approval by the annual general meeting in 2018, the total number of registered shares of DNB ASA will be reduced by up to 0.5 per cent.

BATTLETECH Will Release In 2018

STOCKHOLM - August 14, 2017 - Paradox Interactive and Harebrained Schemes today announced that the release of BATTLETECH has been moved to early 2018. Initially planned for release later this year, the move will give the Harebrained Schemes team the time they need to deliver the type of quality experience the company is known for. "Throughout development our Backers have been clear: ‘Don’t rush it, just make it great.’ and we have taken that advice to heart," said Jordan Weisman, CEO of Harebrained Schemes and creator of the original board game and BattleTech universe. "HBS, Paradox, and our Backers all share a deeply personal attachment to this project and we are committed to delivering a game that not only meets the high expectations of our Backers and fans but introduces BattleTech to a new generation of players." "The feedback and enthusiasm from Beta participants has shown us just how great BATTLETECH can be, and rushing development to fit a timeline would be a disservice," said Fredrik Wester, CEO of Paradox Interactive. "We believe in the Harebrained Schemes team, and want them to give the game the time and attention they need to create a turn-based game worthy of the name." To help eager MechCommanders pass the time, Harebrained Schemes is again updating their Backer Beta this week to include a large number of improvements including gameplay changes, AI upgrades, balance changes, and interface enhancements based upon the reams of useful feedback they’ve received from their community. A subsequent update coming soon will also allow Backers to go head-to-head in PvP multiplayer allowing them to test their skills against human opponents. The Beta will last at least another month, so players interested in becoming Late Backers to gain access to the Beta should go to http://battletechgame.com/ to get in on the action.

Clas Ohlson’s sales performance in July 2017

Compared with the same month previous year, the net store portfolio was expanded by11 stores. At the end of the period, the total number of stores was 218. Sales in July is distributed as follows: +------------+---------+---------+-----------------+------------------+|Countries,  |July |July |Percentage change|Percentage change,||MSEK |  2017/18|  2016/17| |  local currency |+------------+---------+---------+-----------------+------------------+|Sweden |276 |291 |-5 |-5 |+------------+---------+---------+-----------------+------------------+|Norway |250 |251 |0 |-1 |+------------+---------+---------+-----------------+------------------+|Finland |70 |69 |+2 |0 |+------------+---------+---------+-----------------+------------------+|Outside |19 |23 |-17 |-14 ||Nordic | | | | ||countries* | | | | |+------------+---------+---------+-----------------+------------------+| |616 |635 |-3 |-3 |+------------+---------+---------+-----------------+------------------+ *Effected by store optimization in the UK.  Total sales during the first three months of the fiscal year (May to July 2017) increased by1 per cent to 1,783 MSEK (1,763). In local currencies, sales was unchanged. The first quarter interim report 2017/18 will be published at 07:00 CET on Wednesday6 September 2017. The report will be presented on the same day at 08:30 CET in Clas Ohlson’s store at Drottninggatan 53 in Stockholm, Sweden. This is information that Clas Ohlson AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:00 am CET on 15 August 2017.

THQ Nordic AB (publ) publishes Q2 for 2017

Second quarter 2017 ·  Net sales increased by 62% to SEK 85.6 m (52.7). ·  Owned titles represented SEK 65.2 m (38.6), or 77%, of net sales in the quarter. ·  EBITDA was SEK 39.7 m (23.2), corresponding to an EBITDA margin of 46%. ·  Cash flow from operating activities amounted to SEK 21.6 m (2.0). ·  Earnings per share amounted to SEK 0.32 (0.18). ·  5 owned titles and 2 publishing titles launched in the second quarter. All comparatives within parentheses refer to the corresponding period of the previous year, unless otherwise stated. For additional information, please contact:Lars Wingefors, Group CEOTel: +46 708 471 978E-post: lwingefors@thqnordic.com About THQ NordicThe company acquires, develops and publishes PC and console games. The company has a wide catalogue of 270 games, including 81 owned franchises, such as Darksiders, Titan Quest, MX vs ATV, Red Faction, Destroy All Humans, Aquanox, ELEX, Jagged Alliance, SpellForce and The Guild. THQ Nordic has a global publishing reach within marketing, sales and distribution, both online and offline. The Group’s head office is based in Karlstad, Sweden and its operational office in Vienna, Austria. THQ Nordic employs and contractually collaborates 423 people and has four inhouse development studios based in Germany, USA and Sweden. THQ Nordic shares is public listed on Nasdaq First North Stockholm under the ticker THQNB:SS with FNCA Sweden AB as its Certified Adviser. For more information, please visit: http://www.thqnordic-investors.com or http://www.thqnordic.com. This information is information that THQ Nordic is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.00 CET on August 15, 2017.

THE MARKETING GROUP PLC FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2017

London – 15 August 2017 - The Marketing Group plc (“TMG” or the “Group” or the “Company”) is pleased to announce its financial results for the half year ended 30 June 2017. First half highlights ·Turnover of €12.546 million ·EBITDA of €770k ·Goodwill impairment and divestment charge €43.575 million · The balance sheet value of TMG’s investments has now been adjusted to reflect current performance Post period highlights ·July 2017 - Mary Keane-Dawson appointed as Global CEO, Performance Media ·August 2017 - Imagine Group, Skye Multimedia and Wilkin Marketing leave the Group The Group’s third quarter results for the months ended 30 September 2017 will be announced on 15 November 2017.  Commenting, Adam Graham, TMG CEO, said, “Now that this period of internal focus is complete, we can place our full attention on accelerating sustainable growth. I am very confident about the future.” CEO’s statementWe have now completed the bulk of the internal reorganisation of the group and addressed the under-performing areas. H1 2017 EBITDA is €771k, with trading performance for the second quarter improved significantly with EBITDA coming in at €473k and now divestment negotiations have been concluded, the trading results for Q1 have been uplifted by €173k to €298k. We are confident that we have now dealt with the legacy issues and have a strong platform for growth going forward. All agencies in the Group have a clear strategic fit and provide complementary services that will form the cornerstone of our growing network. Three agencies have now left the group (Imagine Group, Skye Multimedia and Wilkin Marketing) and two agencies have been promoted to top tier status (DAE and Digital Virtue). Now that we have significantly improved the infrastructure, I firmly believe that new acquisitions will slot in smoothly. Future targets will be vetted carefully and selected on the basis that they complement the strategy of the group and unlock incremental value. Of course, there will undoubtedly be unforeseen bumps in the road ahead, however the Group is in a much better position to deal with any further challenges it might face. TMG strategyTMG aims to fill a significant niche between the big holding companies and the smaller independent agencies. By structuring itself in a more progressive way, TMG is able to attract top quality agencies that do not wish to “sell out” to the usual suspects. There are also a great many brands that like to engage independent agencies but require a global presence and a lower risk profile. TMG provides a middle ground between these two extremes and gives the best of both worlds: “independent spirit – global scale”.  The big advertising networks were created in a previous era, before modern technology had made the world a smaller place. One no longer needs people in every territory to address a global market. By having offices in key locations, and by using technology to facilitate real- time communication, much more effective solutions can be provided. By flattening the hierarchy, removing the bureaucracy, and empowering people to make decisions, we can respond quickly to change and provide much better value to clients. TMG is effectively building a marketing platform that cuts through the red tape so many networks are tied up in. We are investing in technology that unlocks this potential and creates a much more scalable business. Future acquisitions will complement this approach. We will continue to deepen our commitment to data, measurement and transparency. We aim to develop a best in class performance media axis that can service brands nationally and globally. The combination of focusing on highly effective communications techniques and our strong commitment to streamlined internal processes supports our vision of becoming a highly effective global marketing network. Now that this period of internal focus is complete, we can place our full attention on accelerating sustainable growth. We have all the ingredients to take TMG forward and create something truly special. I am extremely confident about the future and looking forward to the next chapter in TMG’s development.Adam Graham, CEO This information is information that The Marketing Group plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 7.00am CET on 15 August 2017. -ENDS- For further information please contact:Adam Graham, CEOEmail: investorrelations@tmg-plc.com MediaJaime CarronPhone: 0207 1481606Email: jaime.carron@tmg-plc.com Investor relationsClaes Delin / Mikael WidellPhone: +46 703 11 9960E-mail: investorrelations@tmg-plc.com Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider. This information is information that The Marketing Group plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 7.00 am CET on 14 August 2017. The Marketing Group plc (“TMG”) in briefTMG is building a global full-service marketing network that respects the individual cultures of each agency that joins. By providing a supportive platform for growth, and an agile management approach, TMG aims to provide a fresh alternative to the big holding companies: Independent Spirit - Global scale. Each company within the group provides specialist marketing services brought together, within complementary communities of practice, to form an international network that can address a global market. The central team supports its subsidiaries through a lean and nimble structure that can respond quickly to change and provide highly effective solutions for clients. The Marketing Group is listed on Nasdaq First North, Stockholm.  www.tmg-plc.com. Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider. 

Rovio’s revenue increased by 94% in the second quarter

Rovio Entertainment Ltd.’s strong growth continued in the second quarter of 2017, with the company’s revenue increasing to EUR 86.2 million (EUR 44.5 million in Q2/2016). The year-on-year revenue increase was 94.0%, mainly due to the continued strong performance of Rovio’s games, as well as the revenue from The Angry Birds Movie, a global blockbuster animated movie released in May 2016. During second quarter, Rovio also successfully launched two new games – Battle Bay and Angry Birds Evolution. The revenue of the Games business unit increased by 65.0% and amounted to EUR 61.3 million (EUR 37.2 million in Q2/2016). The growth was driven by a 30% increase in the number of monthly paying users and a 51% increase in revenue per monthly paying user. The revenue of the Brand Licensing business unit increased by 242.6% to EUR 24.9 million (EUR 7.3 million in Q2/16). The strong revenue growth was due to revenues from The Angry Birds Movie released in May 2016. Profitability significantly improved in the second quarter of 2017 In the second quarter, Rovio’s adjusted EBITDA increased to EUR 31.6 million (EUR 8.6 million in Q2/2016). The increase was mainly driven by the revenue growth of Games and the revenue from The Angry Birds Movie. In the second quarter of 2017, the adjusted EBITDA margin increased to 36.7% (19.3% in Q2/2016). The adjusted EBITDA of the Games business unit increased by 30.6% to EUR 13.5 million (EUR 10.3 million in Q2/2016), and that of the Brand Licensing business unit increased to EUR 20.7 million (EUR 0.9 million in Q2/2016). The substantial EBITDA growth of the Brand Licensing business was driven by revenues from The Angry Birds Movie. First half of 2017 In the first half of 2017, Rovio’s revenue increased by 94.3% year-on-year and totaled EUR 152.6 million (EUR 78.5 million in H1/2016). The revenue of the Games business unit increased by 76.3% to EUR 117.9 million (EUR 66.9 million in H1/2016). The revenue of the Brand Licensing business unit increased by 197.8% and amounted to EUR 34.6 million (EUR 11.6 million in H1/2016). Rovio’s adjusted EBITDA increased to EUR 41.8 million (EUR 11.0 million in H1/2016). The adjusted EBITDA of the Games business unit increased by 33.9% to EUR 22.5 million (EUR 16.8 million in H1/2016). The adjusted EBITDA of the Brand Licensing business unit increased to EUR 24.3 million (EUR -0.9 million in H1/2016). Key Figures CEO Kati Levoranta comments: “The second quarter of 2017 evidenced true delivery of our Games-First strategy with very strong growth in revenues and profits. During the second quarter, we also finalized Rovio’s restructuring and moved towards a licensing model of lower operating and capital expenses in the consumer products and animated content businesses. The benefits of these structural changes, however, have not yet been reflected in the strong financial performance we achieved in the first half of 2017. Our current top games continued to improve their key KPIs, enabling us to invest in growth and new games with high confidence. Rovio’s latest games, Battle Bay and Angry Birds Evolution, were launched in Q2 with the strongest launch ARPDAU and other KPIs ever seen in Rovio Games business unit. The Brand Licensing business unit saw strong revenue growth due to revenues from The Angry Birds Movie. During the second quarter, we entered into a movie licensing, production and distribution agreement with Columbia Pictures Industries, Inc. regarding Angry Birds movie sequel, scheduled for release in September 2019. I’m very proud of our Rovians. They have all performed at the highest level through the changes in the past few years and made possible our strong profitable growth during the first half of 2017.” Information about figures presented Rovio’s operations are divided into two business units, which also constitute its reporting segments: Games and Brand Licensing. The Games business unit consists of Rovio’s mobile games business. The Brand Licensing business unit consists of two sub-units, Consumer Products and Content Licensing, which generate royalty revenues from licensing the Angry Birds brand to product categories other than mobile games. In addition, Rovio has a third reporting segment, Other, which consists of Hatch Entertainment Oy, 80% of which is owned by Rovio, and unallocated group overhead costs. Hatch Entertainment Oy was incorporated in 2016, and it develops a new way of playing mobile games. Unless otherwise stated, figures in parentheses refer to the comparison period, i.e., the corresponding period in 2016. Adjusted EBITDA refers to EBITDA after adjustments of non-recurring items related to e.g. restructurings. In 1‒6/2017, the adjustments were in total EUR 2.0 million of which EUR 1.9 million related to restructuring of the Brand Licensing unit and EUR 0.1 million in Games. The financial figures are presented according to the IFRS standards. The figures for 4‒6/2017, 4‒6/2016,1‒6/2017 and 1‒6/2016 are unaudited. For further information: Rovio communications, +358 40 485 8985, comms@rovio.comCEO Kati Levoranta and CFO René Lindell are available for comments on August 15, 2017 at 10 a.m.‒12 a.m. (EET). 

NCC to build car showroom for Castellum

“Smista Allé is one of our most prioritized development areas and this project, the Spejaren 4 property block, will be one of the last in the area. The building, which we will construct together with NCC, is in an ideal location for a showroom directly adjacent to the E4 expressway,” says Anders Nilsson, regional managing director at Castellum. The car showroom will total slightly more than 25,000 square meters and comprise four stories. Two stories will be used as showrooms and offices and two stories as garage and parking space for cars. The building will have a Silver environmental rating from the Sweden Green Building Council. The project is divided into two phases. The first phase is complete, and included planning, project engineering and preparatory groundwork. The second phase will now begin and concerns the construction. “Together with Castellum, we are building a state-of-the-art car showroom on previously undeveloped land. NCC will carry out both groundwork and civil engineering works as well as the construction phase of the project, which is part of Castellum’s development of Smista Allé,” says Henrik Landelius, Head of NCC Building in Sweden. Work is to begin in July and the building is scheduled to be complete at year-end 2018.  The order for approximately SEK 278 million will be registered in the third quarter of 2017, about 83 percent in the NCC Building business area and 17 percent in the Infrastructure business area.

MUNTERS SECOND QUARTER 2017

Second quarter 2017 · The order backlog increased by 21% to SEKm 2,449 (2,025). · Order intake increased by 32% to SEKm 2,234 (1,688) of which 25% organically*. · Net sales increased by 20% to SEKm 1,723 (1,438) of which 12% organically*. · Operating profit (EBIT) decreased by 4% to SEKm 143 (150). · Adjusted EBITA decreased by 3% to SEKm 190 (194), corresponding to an adjusted EBITA margin of 11.0% (13.5). · Net income amounted to SEKm 11 (11). · Cash flow from operating activities was SEKm 86 (19). · Earnings per share amounted to SEK 0.11 (0.58). · Munters Group was successfully listed on Nasdaq Stockholm on May 19, 2017. · Kristian Sildeby was appointed member of the Board. January - June 2017 · Order intake increased by 18% to SEKm 3,888 (3,305), of which 11% organically*. · Net sales increased by 22% to SEKm 3,242 (2,657), of which 15% organically*. · Operating profit (EBIT) decreased by 2% to SEKm 218 (223). · Adjusted EBITA increased by 7% to SEKm 337 (314), corresponding to an adjusted EBITA margin of 10.4% (11.8). · Net income amounted to SEKm -30 (-17). · Cash flow from operating activities was SEKm 66 (73). · Earnings per share amounted to SEK -0.52 (-1.12). * As of Q2 2017 new definition of organic growth where organic growth excludes currency effects.           Presentation / Audiocast / Telephone conferenceA telephone conference will be held 15 August 10.00 CET. CEO John Peter Leesi and CFO Jonas Ågrup will present and comment on the report for the second quarter.  Details for the telephone conference; SE: +46856642665 UK: +442030089811 US: +18558315945 The presentation can also be followed via webcast: http://www.financialhearings.com/event/10287  For further information, please contact: John Peter Leesi, CEO Munters GroupPhone: +46 8 626 63 60 John Womack, Investor RelationsPhone: +46 706 782499 THIS INFORMATION IS INFORMATION THAT MUNTERS GROUP AB IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE FINANCIAL INSTRUMENTS TRADING ACT. THE INFORMATION WAS RELEASED FOR PUBLICATION AT 08:00 CET ON 15 AUGUST 2017. About Munters Founded in 1955, Munters is a leading global provider of energy efficient and mission critical precision climate control solutions for commercial and industrial applications. Munters is organised in four business areas: Air Treatment, Data Centers, AgHort and Mist Elimination, and supported by Global Operations and Global Services organisations. Each of these business areas addresses a set of end markets, customer industries and applications, with an offering based on Munters’ technologies and specialist competencies. The Company operates globally with more than 3,500 FTEs working in over 30 countries to provide Munters’ products and solutions to a diverse range of customers, including a wide range of global blue chip companies, in over 180 countries. Today, the Company has a production footprint that includes 18 major manufacturing facilities and seven assembly units across 16 countries worldwide. Munters reports annual net sales in the region of SEK 6 billion and is listed on Nasdaq Stockholm. For more information see www.munters.com

Castellum invests SEKm 317 in Stockholm’s leading car dealership cluster

The new building is scheduled for completion during the first quarter of 2019. The property will be constructed in four floors. Floor One and Two will comprise premises with a surface of approx. 9,300 sq.m. Floor Three and Four will house an unheated parking garage with a surface area of approx. 13,900 sq.m. A 15-year leasing agreement has been signed with NCG Retail Eijendomme AB – who through British MotorGroup Stockholm will run a car dealership, including service and repair departments for the Jaguar and Land Rover automobile brands. The contract includes approx. 4,000 sq.m. heated premises, and parking on the garage floor. This represents an occupancy rate of 34%, relative to the total annual leasing value of SEKm 24,8. This will be the final new construction along the E4 and Smista Allé, and will include the construction of a noise- and risk-screening barrier from the highway, in consideration of nearby residential areas. Customers will enjoy access to a 180-metre long, extremely well-exposed signage position, directly toward the E4, as well as the upcoming Stockholm Bypass. This marks completion of the development area adjoining Smista Allé, thereby promoting more conveniently located services and even better public transit. To date, Smista is Castellum’s largest development area in the Stockholm region. “We’ve been developing a car dealership cluster in the area since 2004. Once this project is completed, we’ll own and manage 59 000 sq.m. of high-quality showroom, business and workshop premises – most of these in the form of concept buildings for well-known upscale car brands, such as Porsche, Mercedes, Audi, Volkswagen, Mini Cooper, Ford and Lexus”, says Henrik Saxborn, Castellum CEO. After deductions for outstanding commercial papers, Castellum retains unutilized credit of approx. SEK 10 billion, which will be utilized for this investment. For additional information, please contact:Henrik Saxborn, CEO, Phone +46-31 60 74 50Ulrika Danielsson, CFO, Phone +46-31 60 74 74www.castellum.se Castellum is one of the major listed real estate companies in Sweden. The fair value of the real estate portfolio amounts to approx. SEK 76 billion, and comprises of commercial properties for office, retail, warehouse and logistics with a total lettable area of approx. 4.4 million sq.m.  The real estate portfolio is owned and managed under the Castellum brand through a decentralized organization with strong and clear local presence in 20 cities from Copenhagen in the south to Sundsvall in the north. In 2016, Castellum sustainability performance was awarded two top distinctions: First Prize for sustainability reporting in Europe from EPRA and Global Sector Leader, handed out by GRESB which means that Castellum is ranked first in the world within the office- and industrial-properties sector. Further Castellum has been selected as an index component of the Dow Jones Sustainability Indices (DJSI), which includes the companies in all industries in the world with best performance in terms of sustainability. The Castellum share is listed on Nasdaq Stockholm Large Cap. Castellum AB (publ), Box 2269, SE-403 14 Gothenburg | Org nr/Corp Id no SE 556475-5550 | Phone +46 31 60 74 00 Fax +46 31 13 17 55

Interim report January - June 2017

Second quarter 2017 ·Revenues amounted to SEK 289.4 (234.9) million, an increase by 23 % compared to the same period last year. ·Operating profit amounted to SEK 162.3 (142.3) million, an increase by 14 %. ·Profit before tax amounted to SEK 162.3 (142.9) million, and profit after tax amounted to SEK 126.3 (110.6) million. ·Cash flow from operating activities amounted to SEK 139.7 (62.1) million, and cash flow from investing activities amounted to SEK -68.9 (-25.1) million. ·By the end of the period cash and short term placements amounted to SEK 253.2 (143.2) million.   ·Earnings per share amounted to SEK 1.20 (1.05) per share. ·Revenue from the second quarter of 2017 are mainly attributable to Stellaris, Cities: Skylines, Europa Universalis IV, Hearts of Iron IV and Steel Division: Normandy 44. Important events in the second quarter ·The new game Steel Division: Normandy 44 developed by Eugen Systems was released. ·Cities: Skylines Xbox One Edition was released, for the first time ported to console. Cities: Skylines for PS4 was announced with a scheduled release date in August 2017. ·Prison Architect: Mobile, developed by Introversion Software and Tag Games was released to tablets. ·The new game Surviving Mars, developed by Haemimont Games, was announced with planned release in 2018. ·The new game Battletech, developed by Harebrained Schemes, was announced with planned release in 2017. ·Pillars of Eternity: Complete Edition was announced to PS4 and Xbox One with scheduled release in August 2017. ·Several expansions were released during the period; Death or Dishonor to Hearts of Iron IV, Mandate of Heaven to Europa Universalis IV, Third Rome to Europa Universalis IV, Mass Transit to Cities: Skylines, as well as Utopia to Stellaris. ·Paradox own game fair PDXCon took place in Stockholm in May. ·Paradox Publisher Weekend at Steam started April 6 and lasted until April 10. ·Steam Summer Sale started June 22 and continued until July 5. Words from CEO In it for the long haul There’s an enduring myth about the games industry that has its roots in a time when sales of physical copies in stores was the only way to create awareness and gain revenue. The myth in question dictates that only full-priced games contribute to revenue, and that the first week sales of a new game determines its success or failure. The truth is somewhat different. Most companies in the industry today count on one out of five games becoming a resounding success straight off the bat. It’s how well companies handle the other four releases that builds long term success. At Paradox we avoid over-optimistic prognoses and generally keep very conservative forecasts. However we always make sure we have a “go-big” plan prepared in case the game receives an unexpectedly positive reception on the market. The plan enables us to hit the gas pedal quickly when it comes to the development of new content and greater marketing efforts. To put it very simply, you could say that we always hope for the best but plan for the worst. That philosophy - where we don’t plan for monster hits for every launch, but rather count on longer sales periods where our long-tail generates a large part of the revenue - ensures that we can run the company in a sustainable and long term manner. Our second quarter 2017 in many ways illustrates this strategy perfectly. We have released two full-priced games - Steel Division: Normandy 44 and Cities: Skylines for Xbox. Steel Division is co-published together with developer Eugen Systems, which in this case meant we came into the development processes towards the end to assume responsibility over sales, marketing and distribution. The IP is kept by the developer. The pre-order campaign surpassed our expectations significantly and the game has taken a clear position in our portfolio, where we believe it will have a longer period of long-tail sales. Establishing a relationship with Eugen Systems has also been valuable. We now have a working partnership with a developer that has many similarities to our own development studio, Paradox Development Studio. Like them, Eugen Systems are very established and well-known within their niche and have built a large and dedicated community around their games. It was also exciting to release Cities: Skylines on a new platform. In part because there are not many similar titles on Xbox One, but also due to the game’s popularity. The game shot onto several toplists at launch and the reception has been very positive among critics and gamers. Now we are preparing to release Cities: Skylines on Playstation 4 and Pillars of Eternity: Complete Edition on both Xbox: One and PS4. We have also continued to develop our DLC-model, with expansions leading to increased user scores and a steady number of growing active players. Stellaris: Utopia, our best selling expansion to date, is an excellent example of this. During the quarter we have also released the expansions “Death or Dishonor” for Hearts of Iron IV, “Mandate of Heaven” for Europa Universalis IV and “Mass Transit” for Cities: Skylines. All of which have contributed to increased activity in their respective franchises. We ran a Paradox Publisher Weekend on Steam during the quarter, as well as participated in their yearly summer sale. Few things illustrate the strength of our broad portfolio as clearly as the successful sales campaigns during these two activities, something that was also reflected in the financial results from the period. In 2016 we released two large full price titles during Q2 - Hearts of Iron IV and Stellaris. The same quarter 2017 has looked very different yet we increased both our revenue and profit. It’s important to stress yet again that comparing financial results quarterly in the games industry is seldom productive. I have chosen to do so here only to stress the importance of a broad portfolio - comprised of base games, expansions, new and old IPs - and to highlight the important role longtail sales play to create a steady flow of income over time. At the end of the quarter, we had the privilege to welcome Triumph Studios to Paradox. The formal transaction happened during quarter 3, but we announced the acquisition at the end of June. It’s a genuine pleasure to welcome a new and established studio to Paradox, but it’s also a great responsibility. I, and my management team, spent a lot of time in discussions with the co-founders of Triumph Studios throughout the spring to ensure that we had taken a wide range of perspectives under consideration in the acquisition. We looked at the business case, our development methods, future plans and of course company culture. Triumph Studios are a great and natural fit to the Paradox portfolio and now we look forward to an exciting future together. I want to finish up by saying a few words about PDXCon. It’s an event we’ve had at Paradox for more than ten years and its main objective has always been to gather journalists and our developers under one roof, to give the games the media coverage they deserve. Our philosophy has always been to let developers and the games take the spotlight and PDXCon has therefore been characterized by accessibility, personality and not in the least a genuine passion for our games. This year we decided to open PDXCon to the public for the first time. One of the goals was to keep the personal and intimate atmosphere while increasing the number of attendees almost tenfold. During a Thursday to Sunday in May, 750 people from more than 22 countries (including Australia and South Korea) gathered for a proper Paradox party. With a 91% approval rating from our visitors and more than double the media exposure for our titles (compared to GDC and Gamescom) we are more than happy with the outcome of the event. Perhaps the most remarkable feat of all was that, despite of the massive increase in scale, almost every attendee remarked upon how unique the personal interaction with our developers at the event was. For those of us who have been at Paradox a long time, it’s both inspiring and a real energy boost to meet and talk to fans from all over the world. For our developers, those meetings give a very clear understanding of the massive impact their work has on people's lives. For our new employees (many of whom join us as fans), it’s a fantastic introduction to the company and the company culture that they are now a part of. For me personally, PDXCon is an annual stimulant and an event that in many ways feel like a family reunion. To be able, now and in the future, to welcome our players into that setting is something that I consider to be a great honour. Fredrik Wester, CEO Presentation of interim report Fredrik Wester and Andras Vajlok will host a live stream to answer report and financial related questions on our Twitch channel on August 15 at 12:00 PM CET https://www.twitch.tv/paradoxinteractive. Submit your questions before via our forum https://forum.paradoxplaza.com/forum/index.php?threads/quarterly-report-q2-q-a-stream-tuesday-aug-15-at-12-00-noon-cest.1039154/, by e-mailing them to ir@paradoxplaza.com or directly in the Twitch chat. The Twitch chat is open for anyone to view but to post comments or question you will need to create an account.

INTERIM REPORT, January–June 2017

Second quarter of 2017 · Consolidated net sales increased by 16 percent to SEK 603 m (522), of which organic growth amounted to 3 percent. Acquisitions contributed by 10 percent and currency by 3 percent · Net sales in Products & Solutions amounted to SEK 430 m (397) and Installation Services to SEK 207 m (156) · EBITDA before items affecting comparability decreased by 12 percent to SEK 79 m (90) · Operating profit (EBIT) before items affecting comparability decreased by 15 percent to SEK 72 m (84) · Operating profit (EBIT) amounted to SEK 65 m (75) · Operating cash flow amounted to SEK -12 m (50) · Earnings per share before and after dilution were SEK 2.13 (2.31) · A dividend of SEK 3.75 per share was paid January–June 2017 · Consolidated net sales increased by 16 percent to SEK 983 m (846), of which organic growth amounted to 4 percent. Acquisitions contributed by 9 percent and currency by 3 percent · Net sales in Products & Solutions amounted to SEK 729 m (656) and Installation Services to SEK 303 m (236) · EBITDA before items affecting comparability decreased by 12 percent to SEK 94 m (107) · Operating profit (EBIT) before items affecting comparability decreased by 17 percent to SEK 80 m (96) · Operating profit (EBIT) amounted to SEK 69 m (83) · Operating cash flow amounted to SEK -29 m (1) · Earnings per share before and after dilution were SEK 2.07 (2.32) Message from the CEOSecond quarter 2017 sees strong sales growth and margin compression in line with our previous guidance Consolidated net sales for the second quarter rose by 16 percent compared with the second quarter last year, from SEK 522 m to SEK 603 m. Sales were penalized by a late Easter, as the holiday period fell in the second quarter this year. All newly acquired companies contributed according to plan. EBIT before items affecting comparability, at SEK 72 m, was slightly below SEK 84 m last year. This is mainly due to increased raw material costs compared with the corresponding period in 2016. The price increases in our main raw materials have now stabilized but at a higher level than last year. Our own sales price increases are largely in effect and are expected to reach their full impact by the middle of the third quarter. All our three acquisitions continued to contribute positively, in line with the forecasts made at the time of acquisition. In early July, we made our fourth acquisition this year with the acquisition of the Danish company Taasinge Elementer A/S, thereby continuing to deliver on our commitment to expand our business through both internal and external growth. Taasinge Elementer is Denmark’s leading manufacturer for the construction industry of prefabricated roof and facade elements based on wooden frame constructions, with annual sales of approximately SEK 150 million. Both of our operating segments contributed to our consolidated sales growth of 16 percent. While our Products & Solutions operating segment reported a sales increase of 8 percent, our Installation Services operating segment achieved an increase of 33 percent deriving from both continued improvement in demand in the Finnish market and the contribution from acquisitions. Within our Products & Solutions segment, Denmark and Sweden contributed positively despite Easter falling in the second quarter this year. Sales in Finland decreased, due to lower demand in the Builders Merchants segment where the consumer market was negatively affected by unfavourable weather conditions. Sales in Norway decreased by 8 percent, due to high competition and instability within the Builders Merchants segment. SealEco showed strong sales compared with the preceding year, with additional sales from the recently acquired EPDM Systems. Installation Services in Finland achieved a 16 percent sales increase in the second quarter 2017, compared with the corresponding quarter in 2016 and comparable operations. The recently acquired LA Kattohuolto contributed with sales as of 1 May 2017. Our Danish franchise companies continued to perform well during the second quarter, with an improved EBIT contribution compared with the preceding year. Earnings per share for the quarter were 2.13 SEK (2.31). I am pleased to welcome Taasinge Elementer A/S to our Group. The acquisition of Taasinge is an important step forward in our strategy of offering comprehensive solutions for building and infrastructure protection. The company has a unique market position in high-quality prefabrication where the key is knowledge of materials and customer-specific products consisting of flat elements including facades, roofs and decks. Everything Taasinge does is tailor-made to the specific project, and their technical sales force and construction engineers are in close dialogue with the contractors and architects regarding design and solutions. The company has extensive know-how of waterproofing and solutions for roofs and facades, in which a number of products within the Nordic Waterproofing product range are also used. We see good opportunities to broaden our customer base in Denmark, and Taasinge’s product range and manufacturing competence can be exported to other countries where Nordic Waterproofing operates. Taasinge is operated as a separate business unit within the segment Products & Solutions – and Martin Tholstrup, Head of Taasinge, is a new member of Nordic Waterproofing’s Group Management. I am also pleased to confirm that the integration of all four acquired companies is going well. As from today, we have updated our long-term financial targets. Our new profitability target is connected to capital efficiency and the return on capital employed (ROCE) exceeding 15 percent before items affecting comparability. This target level is analogue to the previous EBIT margin target of at least 10 percent, which has been replaced. We believe in our business model with the two segments Products & Solutions and Installation Services, and the new profitability target better reflects the profitability in these segments taking the capital efficiency into account. In addition, we want to exploit the growth potential in full. Profitability, efficient use of capital and increasing shareholder value are at the core of what we do. Vejen, 15 August 2017 Martin Ellis,President and CEO Conference callA conference call for investors, analysts and media will be held today, 15 August 2017, at 10:00 a.m. CET and can be joined online at www.nordicwaterproofing.com. Presentation material for the call will be available on the website one hour before the call.To participate, please dial:From the United Kingdom:          +44 20 3008 9804From Denmark:                          +45 35 44 55 75From Sweden:                           +46 8 566 427 00 Further information can be obtained fromMartin Ellis, President and CEO                          tel: +45 31 21 36 69Jonas Olin, CFO & Investor Relations                   tel: +46 708 29 14 54 This information is information that Nordic Waterproofing Holding A/S is obliged to make public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact persons set out above, at 15 August 2017, 08:00 a.m. CET.

Interim Report January - June 2017 Storytel AB (publ)

Key figures for the Streaming division and Print Publishing Currency: Q2, 2016 Q3, 2016 Q4, 2016 Q1, 2017 Q2, 2017 Q3, 2017thousand SEK   Total: Forecast*StreamingRevenue 111 339 135 703 147 399 155 660 167 008 195 000Contribution 20 961 29 269 32 684 32 133 27 847Profit**Contribution 18,8% 21,6% 22,2% 20,6% 16,7%MarginPaying 291,6 341,5 360,2 381,2 423,2 496,0subscribersSubscriber 23,3 49,9 18,7 21,0 42,0 72,8-base change Streaming,SwedenRevenue 75 284 86 889 91 557 96 177 101 365 110 500Contribution 22 424 29 464 27 073 32 678 31 257ProfitContribution 29,8% 33,9% 29,6% 34,0% 30,8%MarginPaying 193,7 219,9 230,8 241,4 255,8 280,0subscribersSubscriber 13,4 26,2 10,9 10,6 14,4 24,2-base change Streaming,other markets***Revenue 36 055 48 814 55 842 59 483 65 643 84 500Contribution -1 463 -195 5 611 -545 -3 410ProfitContribution -4,1% -0,4% 10,0% -0,9% -5,2%MarginPaying 97,9 121,6 129,4 139,8 167,4 216,0subscribersSubscriber 9,9 23,7 7,8 10,4 27,6 48,6-base change PrintPublishing****Revenue 129 615 133 179 189 258 104 137 111 969Contribution 51 109 48 544 74 367 37 543 37 840Profit*****Contribution 39,43% 36,45% 39,29% 36,05% 33,80%Margin * Forecast based on information available at time of reporting ** Contribution Profit is defined as streaming revenue minus costs for content and marketing *** Storytel Norway included in figures @ 100%, In the consolidated accounts it is reported according to the principle of proportional consolidation. **** Print Publishing refers to physically printed editions. Norstedts publishers and People’s Press are included for all quarters. People’s Press has been included from Q2, 2017 and past quarters have been adjusted accordingly, to allow for comparability. In Group Accounts, all acquisitions are included from date of acquisition.  Internal transactions have been redacted. Barnens bokklubb not included in table. ***** Contribution Profit is defined as revenue minus cost per sold unit, distribution costs, and sales and marketing costs. Comments from the CEO Storytel’s success is largely defined by our ability to lay the building blocks for future growth, constantly allowing us to make our service available to new groups of subscribers. We grow through geographic expansion, through launching onto new digital platforms, and through introducing new types of content or new ways of enjoying stories. During Q2, 2017 we introduced ambitious new initiatives in all of these growth sectors. We launched Storytel in Russia, released Storytel on the Sonos wireless Home Sound System, we introduced journalistic reporting through Storytel Dox, and we created a promotional app for chat stories called Stories. We also moved our head office to the historic Norstedts building on Riddarholmen Island in central Stockholm, where Sweden’s first book was printed six hundred years ago. Thus the circle has been closed, giving our virtual service an excellent physical home base. The summer looks positive, and our forecast for Q3, 2017 is close to 500,000 paying subscribers, in average in Q3 and streaming revenues totalling 195 MSEK, which equates to nearly 50% yearly growth. Streaming, Sweden Storytel Sweden has grown consistently during the past seven years, from 4K (4,000) subscribers in Q2, 2010 to the 256K we averaged during Q2, 2017. During the past two years our yearly growth has been at a stable 60-70K subscribers, and shows no direct signs of slowing down. Out of a Swedish population of eight million people over the age of eighteen, our current subscription rate is 3.2% (compared to Spotify and Netflix respectively, who have reached Swedish rates of 20% and 30%). We still haven’t achieved full brand recognition in Sweden; our Swedish marketing is still proving effective. Thus we believe chances are good that Storytel Sweden will continue to grow in the future. The Swedish contribution profit is steady at just over 30%, which indicates long-term profit-margin stability, with an EBITDA-margin of circa 20% for the Swedish market. According to our forecast, the market for audio-book services in Sweden should eventually reach a rate of six to eight percent of the population at saturation. We expect audiobooks have a similar potential in our other markets, as well. Streaming, other markets Storytel is currently available in six markets outside of Sweden (Norway, Denmark, Finland, The Netherlands, Poland and Russia) and we plan further market expansions during the coming six months. Our non-Swedish subscribers totalled on average 167K in Q2, 2017 which is an increase of 69K from our Q2, 2016 average of 98K.  In recent years we have nearly doubled our individual new-subscriptions rate, and are now growing more quickly outside of Sweden. Revenues per non-Swedish subscriber have increased by circa six percent during the past year, thanks to subscription-price increases in Denmark and Norway during the second half of 2016. The average Swedish vs. non-Swedish revenue per subscriber is now largely the same. In Q2, 2017 our non-Swedish revenues were 66 MSEK, as compared to 36 MSEK in Q2, 2016 (which equates to circa 82% in increased revenues). Our goal is to lead the audio-book market in every language market where we are present, which we so far have achieved in Sweden, Denmark, Norway and The Netherlands. We are now entering a period of rapid international expansion, and our ambition is to greatly increase our international efforts in coming quarters, as we launch and expand our service in a greater number of language markets. In Q2, 2017 we posted a non-Swedish EBITDA loss of ca. 17 MSEK, according to plan. Our non-Swedish investments in marketing and content cost ca. 32 MSEK during Q2, 2017. During Q2, 2017 we launched our service in Russia, but have not yet begun any serious marketing campaigns. Publishing Two years ago Storytel acquired Massolit Förlagsgrupp AB publishers, which was at the time posting considerable losses. Today the situation is completely altered thanks to a clearer focus on adult trade and children’s titles aimed at pleasure reading, as well as a leaner organization. Publishing is an industry beholden to powerful seasonal shifts, in which the fourth quarter is normally meant to change the bottom line from red to black. Therefore we are pleased to announce that our Swedish publishing efforts have largely broken even in terms of their EBITDA profit margins during Q2, 2017. All four of Elena Ferrante’s books in the Naples Quartet have topped the Norstedts sales charts during the quarter. The series, which I highly recommend, is a fantastic tale charting two girls from their youth in Naples in the 1950s, all the way through to old age in the present. Jenny Colgan’s feel-good books about the Little Beach Street Bakery, published by Massolit, have also done very well. The new novel Into the Water by Paula Hawkins hit the shelves in hardback during the past quarter, and hopefully the paperback edition will reach an even broader readership when released, following in the footsteps of The Girl on the Train. Both Rabén & Sjögren and B. Wahlströms continue to publish lists with impressive breadth, but one title nonetheless stands out during Q2, 2017: J. K. Rowling’s Fantastic Beasts and Where to Find Them. September 7th will mark the biggest international book release of the year, with David Lagercrantz’s The Man Who Hunted his Shadow. We hope for the same exceptional success as with the previous novels in Steig Larsson’s Millenium series about Lisbeth Salander. Financial Information Storytel Group and its parent company comply with the Swedish law regarding yearly statements of accounts, as well as BFNAR 2012:1 (Swedish Accounting Standards Board standard 2012:1) concerning annual statements of accounts and group accounts at the K3 tier. The registered parent company is Storytel AB (publicly traded). Storytel A.S. (Norway) is half-owned by Cappelen Damm and is reported here according to the principle of proportional consolidation. Wholly owned subsidiaries are included in the group statement of accounts from their time of registration or acquisition. This report has not been audited by the company’s accountants. Revenues and profits for period (compared to Q2, 2016) The group’s total turnover for Q2, 2017 was 265,899 (120,363) TSEK. Within the Streaming division, Sweden accounted for ca. 60.7% and other markets for ca. 39.3%. Cappelen Damm owns 50% of Storytel A.S. in Norway, which is reported here according to the principle of proportional consolidation. The table on page two includes all subscribers and revenue in Norway, and is included under Streaming, other markets, which is why reported revenue for the table on page two is higher than in the statement of accounts, in order to give a truer indication of revenue per subscriber. The group’s Unit-sale costs during Q2, 2017 totaled 161,073 (77,627) TSEK. Unit-sale costs include costs for the actual production of audiobooks, Cost of Goods Sold of physical books, wharehousing and distribution costs, and royalties paid to other publishers and copyright owners. Other external costs for the group during Q2, 2017 totaled 73,090 (22,002) TSEK. The greatest external costs was marketing. Other significant costs included rental payments, tech services, and consultants. Staffing costs for the group in Q2, 2017 totaled till 53,501 (15,737) TSEK. Publishing requires a greater concentration of staff, which explains the relative increase in staffing costs compared to Q2, 2016, before Norstedts publishers and People’s Press joined the group. Profits before depreciation for the group for Q2, 2017 totaled –8,013 (7,128) TSEK. Depreciation primarily involves depreciation attributable to goodwill and other extra value identified in connection with acquisitions. The largest asset items are connected to the acquisition of Norstedts, Mofibo, and People’s Press. Depreciation from these three purchases totalled app. 11 MSEK per quarter (People’s Press calculated in from Q2, 2017). Other depreciation primarily concerns the purchasing and development of IT-systems. Net Financial Items includes both interest income and interest expenses, as well as realized and unrealized exchange differences. Interest costs from bank loans total app. 2 MSEK. Earnings per share, after taxes, in Q2, 2017 totalled –0.55 SEK, calculated as earnings for the period after taxes, divided by the average number of shares during the period. Group: Financial position and cash flow as of June 30, 2017 (compared to Dec. 31st, 2016) At the end of the period, the group had 109,504 (129,561) TSEK in liquid assets. Solvency was 22.4% (23.8%).  Equity totaled 174,456 (172,472) TSEK. Non-current liabilities to loaning institutions totaled 156,931 (155,161) TSEK. We started to amortize these loans during 2017; the portion that will be amortized during the next twelve months is considered a short-term liability and totals ca. 45 MSEK. During Q2, an acquisition loan of 20 MSEK was taken on in order to help finance the purchase of People’s Press. The rest of the purchase was financed through newly offered stocks and cash. Number of shares and Share-Capital (as of June 30, 2017) There were 48,510,040 registered shares in issuance at the end of the period, divided between 635 A-shares and 48,509,450 B-shares. Share-capital totaled 24,255,020 SEK as of June 30th, 2017. Post-period activity  On August 10, Storytel announced it Danish operations had reached more than 100,000 paying subscribers, equaling a doubling of revenues since Storytel acquired it’s Danish Competitor Mofibo.   Date of next reporting The interim report for January–September 2017 will be released on November 15th, 2017. Stockholm, August 15th, 2017 For more information, please contact: Jonas Tellander, CEO: +46 70 261 61 36 Sofie Zettergren, CFO: +46 70 509 98 08

Minesto awards new foundation supplier

Minesto has completed the procurement of a new foundation construction supplier, following the announcement by the previous contractor in July that it could no longer fulfil its commitments to the project. The new contract has been awarded to the Welsh outfit Jones Bros Ruthin (Civil Engineering) Co Ltd, a civil engineering contractor with more than 60 years of experience in engineering solutions, not least in renewable energy. The foundation will be manufactured in an environment adapted for scaled up production. At the same time, the global consulting firm Arup has been assigned the task of completing and verifying the design of the foundation. The foundation design remains valid, providing great advantages in terms of functionality, logistics and economy. However, given the delivery time for the new foundation, Minesto has to move the installation of its unique tidal energy technology in Holyhead Deep to 2018. "We are well positioned to meet time frames and deliverables towards our public funding partners, to demonstrate the unique advantages of the Deep Green technology and develop this required source of renewable energy. This situation allows us to prepare and perform the upcoming installation with even greater efficiency and precision", said Martin Edlund, CEO of Minesto. For additional information please contact: Dr Martin EdlundCEO, Minesto AB+46 31 29 00 60press@minesto.com  Magnus MatssonCommunications Manager, Minesto AB+46 70 570 75 08press@minesto.com About Minesto Minesto is a marine energy technology company with the mission to minimise the global carbon footprint of the energy industry by enabling commercial power production from low-velocity tidal and ocean currents. Minesto’s award winning and patented product, Deep Green, is the only verified marine power plant that operates cost efficiently in areas with low-velocity currents. In May 2015, Minesto secured a €13m investment from the European Regional Development Fund through the Welsh European Funding Office, for the commercial rollout of Deep Green. Minesto was founded in 2007 and has offices in Gothenburg, Sweden, Holyhead, Wales and Portaferry, Northern Ireland. The major shareholders in Minesto are BGA Invest and Midroc New Technology. The Minesto share (MINEST) is traded on the Nasdaq First North Stockholm stock exchange, with G&W Fondkommission as Certified Adviser. Read more about Minesto at www.minesto.com Press images and other media material is available for download via bit.ly/minestomedia. The information in this press release is such that Minesto AB (publ) shall announce publicly according to the EU Regulation No 596/2014 on market abuse (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 08:45 CEST on 15 August, 2017.

SOTKAMO SILVER ANNOUNCES REMAINING RESULTS OF THE INFILL CORE DRILLING PROGRAM – FURTHER STRENGHTEN THE POTENTIAL OF THE DEPTH EXTENSION

All the assaying of the 12 drill holes (totalling to 1,457.45 meters) drilled from the decline at the Silver Mine in May-June 2017 has been completed. The results of the first eight holes were reported on 31stof July 2017. High silver, gold and base metal concentrations below the current underground mine plans further strengthen the view that the deposit extends to the depth. This indicates a promising exploration target for the development of the Silver Mine and increasing of the Mineral Resource. The Mineral Resource and Ore Reserve estimates of the Silver Mine will be updated in the coming months. Ore grade intersections on the strike continuation of the planned stopes is expected to increase the current Ore Reserve to some extent. Attached table 1 summarizes the best intersections of all 12 drill holes and the location of the holes is shown in picture 1. The best intersections of the earlier unreported holes are in the holes TU17-09 and TU17-11. Drill hole TU17-09 was drilled to the horizon intersected also by the drill holes TU17-05 and TU17-07. The best intersection yielded 8 meters at 123 g/t silver, 0.36 g/t gold, 0.96% lead and 1.51% zinc. Intersection at deeper level yielded 5 meters at 121 g/t silver, 0.51 g/t gold, 0.38% lead and 0.53% zinc. The first intersection is located outside current stope plans and the second one along the strike outside the stope plan and will increase the mineable ore reserve. Drill hole TU17-11 at the depth of ca. 150 meters to the area between two planned stopes. The best intersection yielded 3 meters at 143 g/t silver, 1.25 g/t gold, 0.50% lead and 0.81% zinc. Another 3 meters intersection yielded 77 g/t silver, 0.62 g/t gold, 0.63% lead and 3.35% zinc. “The drilling program and its results provide a sound basis for the further development of ore reserves, the increase of mineral resources, and the deeper parts of the deposit of the Silver Mine. Higher metal and gold concentrations underneath the known ore reserve also boost the development works," says Dr Timo Lindborg, CEO of Sotkamo Silver AB. Stockholm August 15th 2017 Sotkamo Silver AB (publ) Timo Lindborg, CEO This information is information that Sotkamo Silver AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:45 CEST on August 15th, 2017. Contact person Timo Lindborg, CEO of Sotkamo Silver AB, tel. +358 40 508 3507The official Stock Exchange Releases are given in Swedish and there may be differences in the translated versions. Picture 1: Decline, planned stopes and drillholes of this campaign (green) in long section of the Silver Mine. The best intersections of this campaing and earlier holes TU39 and TU76 shown in the picture. Table 1: Collar details and Assays of the best intersections of drillholes TU17-01…TU17-12 About Sotkamo Silver AB Sotkamo Silver AB´s business concept is to exploit mineral deposits in the Nordic countries with positive social and environmental benefits. Sotkamo Silver owns mineral deposits, which contain silver and gold in Finland as well as zinc and gold in Norway. The Company’s main development project is the Silver Mine project in the municipality of Sotkamo. Sotkamo Silver applies SveMin’s & FinnMin’s respective rules of reporting for public mining & exploration companies. Sotkamo Silver has chosen to report mineral resources and ore reserves according to the internationally accepted JORC or NI 43-101 code. The company applies International Financial Reporting Standards (IFRS) as approved by the European Union. The ticker symbol is SOSI in NGM Equity in Stockholm and SOSI1 in NASDAQ OMX Helsinki. ISIN-code for Sotkamo Silver shares is SE0001057910. ISIN- code for share warrants series 2016/2017 are SE0008373880 with the ticker symbol SOSI TO4 in NGM Equity and SOSI1EW116 in NASDAQ OMX Helsinki. The number of outstanding warrants are 20,643,198. The Warrant gives the right to subscribe for one (1) share at 4 SEK in August 2017 Legal Entity Identifier (LEI): 213800R2TQW1OZGYDX93 Read more about Sotkamo Silver on www.silver.fi The Company's press releases and financial reports are distributed via Cision Sverige and are available on www.silver.fi

Increasing demand for virtual solution highlighted in Q2 report

Clavister (Nasdaq: CLAV) announced today in its Q2 2017 report that its virtual security solutions are gaining good traction on the market, with additional orders received from global mobile operators. Additionally, the solution’s flexibility to address non-telecom industries was highlighted through an order from a market-leading datacenter provider. A commission by Nokia for Clavister to be integrated into the cloud based SDN/NFV orchestration by Nuage Networks has been certified, another indication of confidence in the solution. The report also details that enterprise business has received positive feedback from a number of key markets and accounts. In Japan, Canon IT Solutions placed a 1,6 MSEK order in Q2 with more expected in the latter quarters of 2017. Also, an announcement from the Board that John Vestberg has been promoted to President and CEO as well as Viktor Kovacs to the Chairman of the Board heralds new management changes to direct and foster the business. Second quarter 2017 •   Revenues amounted to 21,4 (17,4) MSEK, an increase of 22,6% compared to second quarter in 2016 •   Gross profit amounted to 17,0 (10,9) MSEK, an increase of 56,3% •   Gross margin amounted to 79,7 (62,5) % •   Net profit for the period amounted to -19,2 (-22,9) MSEK •   Cash by the end of the period was 29,6 (17,6) MSEK. In addition, own shares are added at a value of 8,2 MSEK at the end of the quarter, which together with cash and cash equivalents yields a total of 37,8 MSEK. •   Earnings per share amounted to -0,84 (-1,19) SEK This report has not been audited by the company's auditor. The report can be downloaded in full via this link . The report will be presented via webcast, https://tv.streamfabriken.com/clavister-holding-q2-2017, at 9.00 CET, August 15, 2017 at //Ends 

Nordnet in cooperation with Infront – launches new trading application for active savers

In connection with the implementation of Web Trader, Nordnet's proprietary trading application Wintrade will be phased out. The transition will begin in September, and is due to be completed in November. During the fall, Wintrade users will be able to try Infront Web Trader for free. - At Nordnet, we are passionate about creating the world's best offer in investments and savings. As a customer at Nordnet, you should be able to rely on that you always get access to the latest technology in the area. Sometimes we develop the services ourselves and sometimes we provide them through partnerships with leading market players. With Infront Web Trader, we get technology tailored for today's active savers, says Eva Trouin, Country Manager Sweden at Nordnet. Wintrade is a proprietary trading application launched in 2001, and at that time Sweden's first Windows-based real-time application for stock trading. Today, Wintrade has more than 4,000 users. The application requires downloading of a software and can only be used on PC. Infront Web Trader is launched directly from Nordnet's website in a browser, does not require download of separate software and works for both PC and Mac. - We have since long a good cooperation with Nordnet around providing Infront terminals to their Active Trader customers. We look forward to expanding this collaboration by helping Nordnet offer its customers the most modern web technology on the market. The fact that one of the leading digital banks in the Nordic region selects us as a partner, we see as proof that our Web Trader, based on Infronts Web Toolkit, has a high quality and meets the requirements of one of the most demanding customer segments. This strengthens Infront's position as the leading Nordic provider of market data and trading terminals, says Kristian Nesbak, CEO of Infront.

Presentation of Nordic Mining's interim report per 30 June 2017

The presentations will be held in Nordic Mining’s office at Vika Atrium, Munkedamsveien 45 (Entrance A, 5th floor), N-0250 Oslo. We invite investors, analysts and media to attend the presentation. Please give notice of participation by email to post@nordicmining.com or telephone +47-90160941. The interim report will be published at the Oslo Stock Exchange and on Nordic Mining's webpage (www.nordicmining.com). For further information, please contact CFO Lars K. Grøndahl, telephone +47-90160941.Oslo, 15 August 2017Nordic Mining ASANordic Mining ASA (www.nordicmining.com)Nordic Mining ASA (“Nordic Mining” or “the Company”) is a resource company with focus on high-end industrial minerals and metals in Norway and internationally. The Company’s project portfolio is of high international standard and holds a significant economic potential. The Company’s assets are in the Nordic region.Through the subsidiary Nordic Rutile AS Nordic Mining is undertaking a large-scale project development at Engebøfjellet in Sogn and Fjordane where the Company has rights and permits to a substantial eclogite deposit with rutile and garnet. Permits for the project have been granted by the Norwegian government. Nordic Mining has rights for exploration and production of high-purity quartz in Kvinnherad in Hordaland and develops the project through its subsidiary Nordic Quartz AS. Nordic Mining’s associated company Keliber Oy in Finland plans to start mining of lithium bearing spodumene and production of lithium carbonate. Nordic Mining holds exploration rights on the Øksfjord Peninsula in Troms and Finnmark, where the Company has discovered a prospective area of sulphide mineralisation. Through the subsidiary Nordic Ocean Resources AS, Nordic Mining is exploring opportunities related to seabed mineral resources.Nordic Mining is listed on Oslo Axess with ticker symbol “NOM”.

Resolutions at Getinge’s Extraordinary General Meeting

At the Extraordinary General Meeting of Getinge AB held on August 15, 2017, the following was resolved. Amendment of the Articles of Association The Meeting resolved in accordance with the Board’s proposal regarding amendment of the Articles of Association by including a conversion provision entailing that a shareholder of share of Series A may on request convert such share to a share of Series B. The request of conversion shall be addressed to the Board and the company shall without delay notify the conversion to the Swedish Companies Registration Office for registration. Authorisation to resolve on issue of new shares The Meeting resolved in accordance with the Board’s proposal to authorise the Board of Directors to resolve on the issue of new shares with preferential right for the company’s shareholders during the period up to the company’s Annual General Meeting 2018. The total number of shares that may be issued by virtue of the authorisation shall amount to the number of shares corresponding to issue proceeds of approximately SEK 4 billion, and shall be within the limits of the share capital. For further information, please contact: Jeanette Hedén Carlsson Executive Vice President Communications & Brand ManagementPhone: +46 (0)10 335 1003                                E-mail: jeanette.hedencarlsson@getinge.com     Lars MattssonHead of Investor RelationsPhone: +46 (0)10 335 0043E-mail: lars.mattsson@getinge.comAbout GetingeGetinge is a global provider of innovative solutions for operating rooms, intensive care units, sterilization departments and for life science companies and institutions. Based on our firsthand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the everyday life for people - today and tomorrow.

UTA NAACP honored with five top national awards

The University of Texas at Arlington’s National Association for the Advancement of Colored People student chapter received the College Chapter of the Year award for the second year in a row at the 108th NAACP National Convention in Baltimore. In addition to being named College Chapter of the Year, UTA received four other awards:  Best Overall Game Changer, Health Game Changer, Juvenile Justice Game Changer and Largest College Branch in the Nation.   “These awards are an affirmation that our NAACP student chapter is filling its local and national mission of advocating on behalf of its communities,” said Leticia Martinez, director of Multicultural Affairs and NAACP campus adviser. “Through teamwork and dedication, these student leaders consistently strive to help their fellow students find a home at UTA while providing education on local and national contemporary issues.”  The national organization annually recognizes student chapters that strive to represent and magnify the NAACP’s vision. Across the nation, NAACP student chapters focus on training and fine-tuning intellectual and leadership skills through social and political activism. “Being part of the NAACP has opened many doors in my life that I am thankful for. I am able to fight the good fight for all races and mankind while I grow as an individual and leader," said Brandy Fields, UTA NAACP student chapter president. "I have met some of the most amazing people and mentors in this organization on a local, state and national level.” The NAACP works to build a society in which all individuals have equal rights without racial discrimination. Education is a fundamental component of the NAACP’s mission. Its efforts to ensure that graduates are career-ready by ensuring access to teaching, fair discipline, equitable resources and challenging curriculum. The goals of the national organization align with those of the UTA student chapter.  “Our chapter is unique because of coalition building with other entities on campus such as Health Services, Multicultural Affairs, The Center for African American Studies and fellow student groups,” Martinez explained. “The UTA NAACP chapter also partners with local city chapters because our students recognize that promoting equality and inclusion is a community effort.” 

Nordea comment on media enquiry about ongoing investigation by Danish Prosecution Service

Last week Nordea in Denmark as expected received a visit from representatives for the Danish Prosecution Service (the Danish Public Prosecutor for Serious Economic and International Crime, SØIK) as they have now formally opened an investigation.- We had expected the visit. It follows the criticism expressed by the Danish Financial Supervisory Authority in June 2016 regarding violations of anti-money laundering legislation by Nordea Bank Danmark A/S. Back then the case was – in accordance with Danish administrative practice – handed over to the Prosecution Service for further investigation, says Julie Galbo, Chief Risk Officer at Nordea Bank AB.In June 2015 the Danish Financial Supervisory Authority (DFSA) investigated how Nordea in Denmark had followed the regulations regarding anti-money laundering (AML). The outcome was that the DFSA expressed criticism and on 17 June 2016 the case was in accordance with Danish administrative practice handed over to the Prosecution Service for further investigation.- Our focus is to fully cooperate with the Prosecution Service and we are committed to ensuring access to all relevant information, says Julie Galbo and continues:- This case dates back to the summer of 2015, and we are pleased to see that the natural next step in the process is now taking place. We hope to be able to close the case in cooperation with the Danish Prosecution Service as soon as possible.Nordea initiated an Anti-Money Laundering Programme in June 2015. The programme focuses on ensuring robust groupwide standards and processes. As part of this we consolidated the majority of all anti-money laundering activities relating to “know your customer”, sanctions screening and transaction monitoring in one central unit. Further, we are strengthening the functions and processes dedicated to regulatory compliance. A total of 1,500 full-time employees are today focusing on these tasks. Resolving the investigation in question goes hand in hand with these efforts.For further information:Stine Wind, Chief Press Officer, Denmark, +45 40 45 10 72

Circuit Check chooses IFS Applications for engineer-to-order manufacturing ERP

Minneapolis-based Circuit Check will move off of a competing ERP application, and is planning measurable process improvements including: · Increased profits of $250,000 per year or more through improved visibility to resource constraints, decrease in required daily production meetings and by eliminating lost time caused by frequent crashes of their legacy system · Consistent and automated billing processes that enable Circuit Check to efficiently invoice customers based on agreed-upon project milestones · Streamline engineer-to-order processes due to embedded project management, production scheduling, project accounting and 3D CAD design · Multi-currency, multi-language capabilities to support global operations on a single instance of the software “Our business has been evolving towards more project-centric activity as we experience rapid growth in our engineered services division,” Circuit Check CFO, Brad Martin, said. “Implementing IFS Applications will help us streamline our project and revenue lifecycle and pave the way for further growth. Our current customers will also benefit from more consistent administrative processes across our multiple divisons, which will improve their experience collaborating with us on equipment design and delivery.” Mike Lorbiecki, IFS vice president of sales for North America, added, “Global engineer-to-order manufacturers like Circuit Check need ERP to manage the interconnected tasks and processes associated with a complex project, but also accurately capture and bill for earned value as the project progresses according to the contract with their customer. Due to its powerful project accounting and execution functionality, IFS Applications is the solution of choice for these companies, particularly those like Circuit Check that serve demanding sectors like automotive, medical, industrial, telecommunications, consumer and aerospace. Circuit Check also has global operations and multiple divisions, which makes them an even better fit for IFS. We look forward to seeing them leverage IFS Applications to maximize value delivered to current customers and stakeholders and reach new plateaus of growth in the future.” For more information about IFS’s solutions for the industrial manufacturing industry, please visit: http://www.ifsworld.com/corp/industries/industrial-manufacturing/

REVOLUTIONARY LEARNING GAME COMPANY LIGHTNEER LANDS SEED FUNDING AT 5M$

Lightneer , the Finnish learning game studio founded by Rovio (Angry Birds) alumns together with some of the world's top scientists from CERN, Helsinki and Oxford Universities, has closed their seed funding round at 5M$. The round, led by Chicago and San Francisco based GSV Acceleration, was also participated by Helsinki based IPR.VC, Brighteye VC from Paris and Reach Capital from Silicon Valley.     Lightneer leads what it calls a 'fun-learning revolution' and describes itself more of a movement than a regular gaming studio. "After 3 billion downloads, and an extremely knowledgeable fanbase legacy of sling-shotting experts, we thought that what if we could give them something useful within the game mechanics too. Something as fun and entertaining as the best games in the world, with science invisible-learning qualities. What would the world look like, if the best games taught us particle physics?" -Peter Vesterbacka, the former Mighty Eagle of Rovio and present Brand Breaker of Lightneer describes.The gaming industry veterans have been developing their debut learning game Big Bang Legends , together with world's leading science experts. The game focuses on stealth-learning key concepts from physics and chemistry, the story starting from the beginning of matter: the Big Bang. It also features a ground-breaking learning model called "Learn To Play" (instead of "Free To Play"), including more in-depth learning content starting from 0.99 USD / month subscription, with 30 second mini-lectures from world's top scientists, such as the Oxford Professor Marcus du Sautoy and the world's leading anti-matter expert Rolf Landua from CERN.      Lightneer is building an invisible-learning platform powered by a game engine. The first game Big Bang Legends introduces players to all of the 118 atoms of the Periodic Table of Elements rendered as collectible, adorable atom-hero creatures. "Kids can learn hundreds of Pokémons, and all of their features by heart," says Lightneer's CEO Lauri Järvilehto. "How hard can 118 atom-heroes be to learn?"The game has been launched in South East Asia, Hong Kong and Finland. In Asia, the game sky-rocketed to #1 Educational Game right after the launch. In Finland the game charted as the #1 most downloaded game in All Gamescategories on both iOS and Android. Lightneer prepares to launch the game globally in January 2018, with launch activities focused in the US and the UK."With the launch of Big Bang Legends, Lightneer becomes a literal 'game changer', allowing people to learn the fluency of particle physics while having fun and being engaged and challenged." -Deborah Quazzo from GSV Acceleration comments.     The atom-hero characters' Finnish voice actors include some of Finland's most renowned entertainers and celebrities, such as rock star Michael Monroe, Hollywood director Renny Harlin and Finland's #1 pop star Robin. Lightneer will announce the celebrity lineup of the English version in the coming months.The Game is currently available for a free download from Appstore  and Google Play  in Hong Kong, Macau, Taiwan, Singapore, Thailand, Vietnam, Philippines and Finland. Lightneer’s team consists of Finland’s game industry veterans with backgrounds at companies like Rovio, Digital Chocolate and Gameloft. Lightneer’s advisory board includes global gaming and science legends such as Oxford Professor Marcus du Sautoy, CERN Head of Global Outreach Rolf Landua and former Mattel and Sega CEO Tom Kalinske. Lightneer has an official partnership with CERN that states both parties' interest to make science learning more accessible and fun worldwide. Lightneer is funded and supported by GSV Acceleration, IPR.VC, Brighteye VC, Reach Capital, Founders Factory and TEKES.   MEDIA CONTACT FOR INTERVIEWS:Hanna ToivonenPR & Communications Directorhanna@lightneer.com+358 50 42662 00 LINK TO GAME:http://m.onelink.me/911e2feb ELECTRONIC PRESS KIT for logos, screenshots and videos:https://www.dropbox.com/sh/ytroji76cskn64c/AABRr4edwI1-SPBTtnWuT507a?dl=0 WEBSITE: www.lightneer.com HASHTAGS: #lightneer #madeofatoms #bigbanglegends   Lightneer in Uganda (Read more from our blog) 

LINK Mobility Group ASA: Closing completed in connection with acquisition of ViaNett

Reference is made to the stock exchange announcement from LINK Mobility Group ASA ("LINK" or the "Company") on 24 May 2017 regarding signing of a term sheet for the acquisition of ViaNett AS and its fully owned subsidiary Sendega AS ("ViaNett"). LINK has today completed the acquisition of all issued and outstanding shares in ViaNett, whereof approximately 99.88% of the shares are purchased from TargetEveryOne AB, and whereof the remaining 0.12% of the shares in ViaNett have been acquired through a compulsory acquisition for cash only from the remaining minority shareholders. The acquisition was completed based on an agreed enterprise value of approximately NOK 87.18 million (100% basis), reflecting an adjusted estimated EBITDA for ViaNett in 2017 of NOK 15.85 million multiplied by a factor of 5.5. In connection with the acquisition, the board of directors of the Company has issued 230,318 new shares to TargetEveryOne AB as part of the consideration for ViaNett. The share capital increase related to the share issuance is expected to be registered with the Norwegian Register of Business Enterprises on Wednesday 16 August 2017. Aabø-Evensen & Co Advokatfirma AS is acting as legal advisors to LINK in connection with the abovementioned transactions. For further information, please contact:Arild Hustad, CEOLINK Mobility Group ASAArild.Hustad@linkmobility.comMob: +47 95 24 19 30 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Stockmann Group's Half year financial report 1 January - 30 June 2017

STOCKMANN plc, Half year financial report 16.8.2017 at 8:00 EET April-June 2017, continuing operations:- Consolidated revenue was EUR 281.3 million (320.7).- Revenue in comparable businesses was down by 4.0%.- Gross margin was 56.1% (57.3).- Operating result was EUR 14.6 million (17.5). January-June 2017, continuing operations:- Consolidated revenue was EUR 498.1 million (563.9).- Revenue in comparable businesses was down by 2.9%.- Gross margin was 54.9% (55.4).- Operating result was EUR -10.5 million (-8.9). - Earnings per share were EUR -0.42 (-0.36). - In June, Stockmann signed an agreement on the sale of the Stockmann Delicatessen operations in Finland to S Group’s regional cooperatives. If approval is granted by the Finnish Competition and Consumer Authority during 2017, the transaction can be completed at the end of 2017.- The food operations in Finland have been classified as an asset held for sale and reported as discontinued operations. The comparison figures in the Group and Stockmann Retail income statement and related items have been restated accordingly. The comments in the half year financial report refer only to continuing operations.- Stockmann Delicatessen in the Baltic countries will remain with Stockmann and is reported as a part of Stockmann Retail’s continuing operations. Guidance for 2017 remains unchanged:Stockmann expects the Group’s revenue for 2017 to decline due to changes in the store network and product mix. Adjusted operating profit is expected to improve, compared with 2016. CEO LAURI VEIJALAINEN: Stockmann’s strategic journey progressed in the second quarter. As the most visible step, we announced the sale of Stockmann Delicatessen in Finland to S Group. In the quarter, I am particularly satisfied that both Stockmann Retail and Real Estate clearly improved their operating profit, by over EUR 10 million in total. However, due to the weakened profitability of Lindex in Sweden, the Group’s operating result in the quarter was down on the previous year. Stockmann Retail delivered a good second quarter. Comparable revenue has now stabilised and we achieved slight sales growth in fashion and cosmetics. The decisions and actions taken are starting to be visible. As a result, Retail’s operating result improved significantly. A lot remains to be done, but our direction is definitely the correct one. Real Estate continued its stable performance, supported by the strengthened Russian rouble which boosted rental income from the Nevsky shopping centre. An investigation into the possible divestment of the property is ongoing according to plan. For Lindex, revenue and subsequently the result was adversely impacted by the weakening market in Sweden and intensive campaigning. Outside the Nordic countries, Lindex continued to grow its revenue but this was not enough to retain the highest ever operating profit, which Lindex achieved a year ago. Action will be taken to improve sales and profitability. We will also continue to invest in digitalisation and strong campaigns, to succeed during the important autumn season. We continue to focus on our key businesses and improving profitability in all three divisions. I am confident that we now have the capabilities to drive growth again in our Stockmann Retail business and to make this division profitable in 2018. KEY FIGURES Continuing operations 4-6/ Restated Restated Restated Restated 2017 4-6/ 1-6/ 1-6/ 1-12/ 2016 2017 2016 2016Revenue, EUR mill. 281.3 320.7 498.1 563.9 1 175.7Gross margin, % 56.1 57.3 54.9 55.4 55.8EBITDA, EUR mill. 29.5 32.0 19.4 19.1 85.6Adjusted EBITDA*, EUR mill. 29.5 32.0 19.4 19.1 88.2Operating result (EBIT), EUR 14.6 17.5 -10.5 -8.9 28.3mill.Adjusted operating result 14.6 17.5 -10.5 -8.9 30.9(EBIT)*, EUR mill.Net financial items**, EUR mill. -10.8 -4.7 -15.4 -8.9 -23.1Result before tax, EUR mill. 3.8 12.8 -25.9 -17.8 5.2Result for the period, EUR mill. -1.1 4.6 -28.0 -23.0 -7.5Earnings per share, -0.03 0.05 -0.42 -0.36 -0.18undiluted and diluted, EURPersonnel, average 7 224 8 273 7 217 8 343 8 151 Continuing and discontinued 4-6/ 4-6/ 1-6/ 1-6/ 1-12/operations*** 2017 2016 2017 2016 2016Net earnings per share, -0.09 -0.04 -0.52 -0.35 -0.12undiluted and diluted, EURCash flow from operating 48.2 54.4 -29.9 -20.9 41.5activities, EUR mill.Capital expenditure, EUR mill. 7.9 13.6 15.7 19.5 44.2Equity per share, EUR 14.32 14.19 14.99Net gearing, % 76.5 76.2 68.3Equity ratio, % 46.9 46.0 48.3Number of shares, undiluted and 72 049 72 049 72 049diluted, weighted average, 1 000pcReturn on capital employed, 1.3 -4.6 1.8rolling 12 months, % * There were no adjustments made in the second quarter, neither in 2017 nor in 2016. For full-year 2016, adjustments affecting operating result were EUR 2.6 million and they were mostly related to ICT outsourcing.** Includes a write-off of EUR 3.8 million related to Stockmann’s investment in Tuko Logistics Cooperative.*** Discontinued operations include department store operations in Russia which were sold in the first quarter of 2016, and Stockmann Delicatessen food operations in Finland which are expected to be divested at the end of 2017. Stockmann uses Alternative Performance Measures according to the guidelines of the European Securities and Market Authority (ESMA) to better reflect the operational business performance and to facilitate comparisons between financial periods. Gross profit is calculated by deducting the costs of goods sold from the revenue, and gross margin is calculated by dividing gross profit by the revenue as a percentage. EBITDA is calculated from operating result excluding depreciation. Adjusted EBITDA and adjusted operating result (EBIT) are measures which exclude non-recurring items affecting comparability from the reported EBITDA and reported operating result (EBIT). Stockmann also uses the term “revenue in comparable businesses” which refers to revenue excluding Hobby Hall, which was divested on 31 December 2016, the Oulu department store, which was closed on 31 January 2017, and the Lindex stores in Russia, which were closed in 2016. OUTLOOK FOR 2017 In the Stockmann Group’s largest operating country, Finland, the economy has begun to recover. GDP and the retail market are expected to grow in 2017. Consumers’ purchasing power is, however, not expected to increase and purchasing behaviour is changing due to digitalisation and increasing competition. The Swedish economy remained stable in 2016 and the GDP growth estimate for 2017 remains on a higher level than in Finland. The steady growth in the fashion market stagnated in 2016, and the market is expected to decline in 2017. In the Baltic countries, GDP growth is estimated to continue. The outlook for these countries is expected to be better than that for the Stockmann Group’s other market areas. The Russian economy is expected to recover gradually, but the purchasing power of Russian consumers remains low. Stockmann will continue improving the Group’s long-term competitiveness and profitability. The efficiency measures launched in summer 2016 will be fully visible in the 2017 operating costs. Improvements in the operating result in 2017 are estimated to come mainly from the Stockmann Retail division, which is still loss-making, while Real Estate is expected to continue its stable profitable performance. Lindex’s operating profit in 2017 will be clearly down on the previous year’s record-high earnings. The planned sale of the Delicatessen business in Finland is expected to improve the Group’s profitability from 2018 onwards. Capital expenditure for 2017 is estimated to be approximately EUR 45-50 million, which is less than the estimated depreciation for the year. GUIDANCE FOR 2017 Stockmann expects the Group’s revenue for 2017 to decline due to changes in the store network and product mix. Adjusted operating profit is expected to improve, compared with 2016. Half year financial report 2017This company announcement is a summary of the Stockmann's Half year financial report 2017 and includes the most relevant information of the report. The complete report is attached to this release as a pdf file and is also available on the company's website at stockmanngroup.com . Press and analyst briefingA press and analyst briefing will be held today, on 16 August 2017 at 9:15 a.m. EET in the Fazer À la Carte restaurant on the 8th floor of Stockmann’s Helsinki city centre department store, Aleksanterinkatu 52 B. WebcastCEO Lauri Veijalainen will host a webcast in English today, on 16 August 2017, at 11:15 a.m. EET presenting the Half year financial report. To participate in the webcast, please dial one of the numbers below 5–10 minutes before the webcast begins. The presentation can be followed by this link  or on the address stockmanngroup.com.  The recording and presentation material are available on the company's website after the event. Finland: +358 (0)9 7479 0404Sweden: +46 (0)8 5065 3942United Kingdom: +44 (0)330 336 9411United States of America: +1 719 457 1063 Confirmation code: 8630953 Further information:Lauri Veijalainen, CEO, tel. +358 9 121 5062Nora Malin, Director, Corporate Communications, tel. +358 9 121 3558 www.stockmanngroup.com STOCKMANN plc Lauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

ICA Gruppen Q2 report 2017

Second quarter of 2017 in summary · Consolidated net sales amounted to SEK 27,198 million (26,222), an increase of 3.7% · Operating profit excluding non-recurring items totalled SEK 1,094 million (1,154) · The sale of ICA Real Estate in Norway and inkClub, and costs ahead of the integration of the acquisition of IKI in Lithuania, affected operating profit excluding nonrecurring items by a combined total of SEK -53 million · Profit for the period was SEK 1,021 million (829). Profit includes capital gains on sales of non-current assets and impairment losses totalling SEK 165 million net (-37) · Earnings per share were SEK 5.06 (4.12) · Cash flow from operating activities amounted to SEK 2,001 million (1,785). Excluding ICA Bank, cash flow was SEK 1,836 million (1,463) · The sale of 12 properties to Secore Fastigheter was completed on 2 June, generating a capital gain of approximately SEK 150 million After the end of the quarter · No significant events have taken place after the end of the quarter Comment from the CEO of ICA Gruppen, Per Strömberg: “We had stable underlying earnings during the second quarter, with Apotek Hjärtat – above all – posting a good quarter. Other businesses have been affected by divestments to varying degrees – particularly the sale of properties in Norway – as well as by ongoing activities and ventures. Higher costs have resulted in a slightly lower operating margin than a year ago, but with a high level of activity it is at the same time natural that there will be variations from quarter to quarter that affect earnings. In the long-term perspective we are on track to meeting our targets.” For further information, please contact: Frans Benson, Head of Investor Relations tel. +46 8-561 500 20 ICA Gruppen press service Tel +46 10 422 52 52 Press and analyst meeting ICA Gruppen is arranging a press and analyst meeting on Wednesday 16 August at 10.00 CET at Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm. CEO Per Strömberg and CFO Sven Lindskog will present the interim report. The conference can also be followed at www.icagruppen.se/investerare. To call in, please dial:    SE +46 8 5050 3050                    UK +44 203 655 1001                Conference PIN: 1839741# Calendar 10 November 2017                Interim report third quarter 14 December 2017                Capital Markets Day 8 February 2018                    Year-end report 2017 This information is such that ICA Gruppen AB is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at time 07.00 CET on Wednesday, August 16, 2017.

Asetek – Q2 2017: Revenue Growth Driven by Gaming PC Cooling Demand

Asetek reported revenue of $11.1 million in the second quarter of 2017, an increase of 33% from the second quarter of 2016 on higher desktop revenue driven by shipments in the DIY and Gaming Performance/ Desktop PC markets. Growth in the quarter also reflects an increase in shipment of data center products to OEMs. Revenue for the six months ending 30 June was $22.6 million, an increase of 21% from the same period of 2016.  “Q2 was another good quarter for Asetek. The demand for our efficient liquid cooling solutions for data centers, servers and PCs continues to grow. For 2017, we expect a decent growth within our desktop segment, especially due to high-end gaming customers. And we expect significant growth within our data center segment on the back of continued progress with OEM partners and increasing end-user adoption with technology deployed to new high performance (HPC) installations. Our job now is to make sure the positive development continues,” said André Sloth Eriksen, CEO and Founder.  EBITDA adjusted for share based compensation expense was was $1.1 million in the second quarter of 2017, compared with EBITDA adjusted of $0.3 million in the second quarter of 2016. First-half 2017 EBITDA adjusted was $1.8 million, compared to $1.6 million for the first half of 2016. Desktop revenue was $10.1 million in the second quarter, an increase of 34% from the same period of 2016. Operating profit from the desktop segment was $2.8 million, an increase from $2.2 million in the same period last year due to an increase in DIY and Gaming Performance/Desktop PC sales. Data center revenue was $1.0 million, an increase from $0.8 million in the prior year due to an increase in shipments to OEM customers, partly offset by a decline in shipments under government contracts. Revenue variability is expected to continue while the Company secures new OEM partners and growth of end-user adoption through existing OEM partners. Asetek continued to invest in its data center business and the segment operating loss was $1.6 million for the second quarter, compared with $1.3 million in the same period of 2016. Expenditures relate to technology development, manufacturing, and sales development with data center partners and OEM customers. Through new and repeat orders received from data center OEM partners in the first half of 2017, Asetek is increasing its end-user adoption with technology deployed to new HPC installations.  In the second quarter, this included orders of RackCDU D2C™ (Direct-to-Chip) liquid cooling from Fujitsu and Penguin Computing. Due to continued positive development within the desktop segment, Asetek increases its full year 2017 desktop revenue guidance from single digit growth to growth between 10% and 20% compared with 2016.  The outlook for the data center business is reaffirmed, with significant revenue growth expected compared with 2016. Webcast and conference call at 8:30 AM CEST today 16 August 2017  Asetek will release its financial results for the second quarter 2017 on Wednesday, 16 August at 7:00 AM CEST. This is followed by a presentation by CEO André Sloth Eriksen and CFO Peter Dam Madsen at 8:30 AM CEST. Asetek invites investors, analysts and media to join the presentation. The presentation is expected to last one hour, including Q&A, and can be followed through live webcast or by conference call. Conference call – audio only:  Please dial in 5-10 minutes prior using the phone numbers and confirmation code below: +-----------------------------------------+------------------------------+|Copenhagen, Denmark:                     |+4532 71 16 59                |+-----------------------------------------+------------------------------+|Oslo, Norway: |+472350 0486 |+-----------------------------------------+------------------------------+|Stockholm, Sweden: |+46(0)8 5033 6538 |+-----------------------------------------+------------------------------+|Frankfurt, Germany: |+49(0)69 2222 10629 |+-----------------------------------------+------------------------------+|London, United Kingdom: |+44(0)20 3427 1916 |+-----------------------------------------+------------------------------+|Paris, France: |+33(0)1 76 77 22 29 |+-----------------------------------------+------------------------------+|New York, United States of America: |+1646 254 3362 |+-----------------------------------------+------------------------------+|Confirmation code: 5557928 |+-----------------------------------------+------------------------------+ Webcast – audio and slide presentation: Please join the second quarter 2017 results webcast by clicking here . The Second Quarter 2017 Report and presentation will also be made available on www.asetek.com and www.newsweb.no, as well as through news agencies. A recorded version of the presentation will be made available on www.asetek.com approximately two hours after the broadcast has concluded. Asetek’s press room is available on www.asetek.com/press-room/news/  For questions or further information, please contact:  CEO and Founder André S. Eriksen, +45 2125 7076, email: ceo@astek.comCFO Peter Dam Madsen, +45 2080 7200, email: investor.relations@asetek.com About Asetek:Asetek is the global leader in liquid cooling solutions for data centers, servers and PCs. Founded in 2000, Asetek is headquartered in Denmark and has operations in California, Texas, China and Taiwan. Asetek is listed on the Oslo Stock Exchange (ASETEK.OL). 

ICA Gruppen’s Sustainability Report for second quarter 2017

“By virtue of our size we have a great responsibility, but on top of this we also clearly see that sustainability is a driver of growth. We see it in our figures, and it is also evident in numerous, independent studies. Companies with effective sustainability work are on average more profitable and deliver higher returns to their shareholders,” says Per Strömberg, CEO ICA Gruppen in his comments on the report. See the Sustainability Report for more information, including: · ICA Gruppen’s greenhouse gas emissions decreased by 41% during the period July 2016–June 2017 compared with the base year 2006. · Continued growth in sales of ecolabelled, organic and ethically labelled products in ICA Sweden’s central assortment. In total, sales of such products during the period July 2016–June 2017 grew 8% compared with the corresponding period a year ago. · New packaging contributing to lower food waste. By changing over to a new form of packaging for large parts of the meat range, considerably longer shelf life has been achieved as well as improved flavour. · Food waste becomes fish in circular system. Waste from potatoes is being used to breed insects, which in turn are being used as fish feed for Arctic char sold under ICA Sweden’s private label. · During the spring Apotek Hjärtat changed over to using plastic bags made of sugar cane. When incinerated the bags produce 85% less CO2than petroleum-based bags. For more informationICA Gruppen press service, Telephone number: +46 10 422 52 52

MenaQ7® Vitamin K2 Again Shown to Inhibit Hardening of Arteries: New Study

OSLO, NORWAY and METUCHEN, NJ (August 16th, 2017) – A new study1 of renal transplant recipients, a group shown to express subclinical vitamin K deficiency, examined whether K2 supplementation would correct this deficiency and thus improve arterial stiffness. The study has published in Journal of the American Society of Hypertension, and the vitamin K2 used in the study was MenaQ7® Vitamin K2 as MK-7 from NattoPharma. This Lebanese study evaluated in the KING trial (a single-arm pilot study) to see if there is an association between vitamin K2 supplementation and the change in both subclinical vitamin K status and indices of arterial stiffness among 60 renal transplant recipients with stable graft function. The results showed that 8 weeks of MK-7 supplementation (360 mcg/day as MenaQ7®) was associated with significant improvement in arterial stiffness and 24-hour peripheral and central pressures. The mean reduction in cfPWV was 1.4 m/s, which was well beyond the reduction of 1 m/s recommended for a clinically relevant vascular effect. “While our previous cardiovascular study in healthy postmenopausal women showed an improvement in arterial elasticity after 3 years of supplementation, the results collected in this trial are staggering, especially as the statistically significant effect was seen very quickly,” says Hogne Vik, chief medical officer of NattoPharma. “After just 8 weeks of MK-7 supplementation, low vitamin K status represented by dpucMGP level was significantly reduced by 55.1%. Moreover, supplementation was associated with a 14.2% reduction in mean cfPWV. “One can assume that longer MK-7 supplementation may lead to even better results, and secure improvement in cardiovascular outcomes in renal transplant patients.”  According to the researchers, prior observational studies have shown the prevalence of subclinical vitamin K deficiency has been reported to be as high as 80% in the renal transplant population. Moreover, in kidney transplant recipients, Vitamin K insufficiency, expressed as a high circulating level of dp-ucMGP (dephosphorylated-uncarboxylated matrix Gla protein, or “inactive” MGP, a K-dependent protein), is associated independently with increased risk of mortality. However, any studies to date have not addressed whether vitamin K supplementation may lead to improved outcomes after kidney transplantation.  In addition, MK-7 supplementation improved vitamin K status, which was represented by the reduction in dp-ucMGP concentrations. A positive correlation was present between the reduction in arterial stiffness, a surrogate of early cardiovascular disease, and the circulating concentration of dp-ucMGP, a marker of subclinical vascular vitamin K deficiency and calcification. The main conclusion was that, among renal transplant recipients with stable graft function, vitamin K2 supplementation was associated with improvement in subclinical K deficiency and arterial stiffness. According to the researchers, the findings from this trial support the hypothesis that subclinical vitamin K deficiency may be a modifiable cardiovascular risk factor and may improve with MK-7 supplementation. “NattoPharma was excited to participate in this clinical trial,” adds Dr. Vik. “We have dedicated ourselves to cultivating an understanding of the benefits Vitamin K2 offers to human health, and in that work have recognized that vitamin K2 deficiency can have serious implications on arterial health. This study adds to the body of evidence confirming the cardiovascular support MenaQ7® Vitamin K2 as MK-7 provides, and continues to solidify the hope this important nutrient offers the global population.” Reference: 1 Mansour AG et al. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients – a single-arm, single-center clinical trial. J Am Soc Hypertens. 2017 Jul 13. Pii: S1933-1711(17)30255-3. # # # About NattoPharma and MenaQ7® NattoPharma ASA, based in Norway, is the world’s leader in vitamin K2 research and development. NattoPharma is the exclusive international supplier of MenaQ7® Vitamin K2 as MK-7, the best documented, vitamin K2 as menaquinone-7 (MK-7) with guaranteed actives and stability, clinical substantiation, and international patents granted and pending. The company has a multi-year research and development program to substantiate and discover the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements. With a global presence, the company established its North American subsidiary, NattoPharma USA, Inc., in Metuchen, NJ, and NattoPharma R&D Ltd. in Cyprus. For more information, visit www.nattopharma.com or www.menaq7.com. For more information, please contact: Kate Quackenbush, NattoPharma Director of Communications Phone: 609-643-0749 x 220 E-mail: kate.quackenbush@nattopharma.com

Isofol establish cooperation with Prof. Sten Nilsson and Dr. Alain Herrera in preparation for the upcoming pivotal trial with Modufolin®

Isofol Medical AB (publ), a clinical stage oncology company, announces that a cooperation has been established with Professor Sten Nilsson and Doctor Alain Herrera who have joined Isofol as advisors to its Board of Directors. In addition to several of the World’s leading oncologists being part of Isofol’s Advisory Board this strengthens the company with additional expertise within pharmaceutical business strategy, clinical development, and management of the registration process in preparations for the upcoming pivotal study ISO-CC-007, where Modufolin®, with the support of both FDA in the USA and EMA in Europe, is evaluated as a first-line treatment for metastatic colorectal cancer in an effort to provide data for directly taking Modufolin® to potential drug marketing approval. Professor Sten Nilsson Dr. Nilsson, MD, PhD, is one of Scandinavia's leading clinicians in urological oncology. He has served as a Professor of Oncology at the Karolinska Hospital, Stockholm, Sweden and has wide ranging clinical and research experience in the fields of oncology and nuclear medicine. In the industry, Prof. Nilsson has been part of the advisory boards of several leading pharmaceutical companies such as Bayer Healthcare, Janssen, Ipsen, Novartis, AstraZeneca, Pharmacia/Pfizer, Roche and Lilly. He is founder of Dextech Medical (Aktietorget, Stockholm) and is providing scientific and strategic advice as a member of the board of PledPharma (Nasdaq First North), and Spago Nanomedical (Aktietorget, Stockholm).  Doctor Alain Herrera Dr. Alain Herrera, MD, PhD has contributed directly to the worldwide registration of, among others, the cytostatic oxaliplatin. Oxaliplatin in combination with fluorouracil and leucovorin constitute one of today’s basic regimens, FOLFOX, in treatment of colorectal cancer. Currently Dr. Herrera operates as a Senior Consultant within the field of Oncology. Prior to this Dr. Herrera held the position of Vice President of Global Oncology Business Strategy and Development at Sanofi and before that he was Head of Global Oncology Franchise at Sanofi. Dr. Herrera has also served as Chairman of Chiron Therapeutics Europe and as Managing Director of Pierre Fabre Oncology Laboratories. Dr. Herrera is part of the Supervisory Board of, among others; IDDI, Nanobiotix, PDCline Pharma, Gustave Roussy-Transfert and Arcad Foundation. For more information, please contact: Anders Rabbe, CEO, Isofol Medical AB E­mail: anders.rabbe@isofolmedical.com Phone: +46 (0)707 646 500 About Modufolin® Modufolin® (active ingredient [6R]-5,10-methylenetetrahydrofolate), is a novel folate-based compound developed to increase the efficacy and reduce the side effects of antimetabolites used in cancer treatment. It is the key active metabolite of the widely used folate-based drugs leucovorin and levoleucovorin. As Modufolin® does not require metabolic activation to exert its effect, Modufolin® is suitable for all patients irrespective of their capacity to activate folates. Modufolin® is currently being evaluated in a clinical Phase II study. About Isofol Medical AB Isofol Medical AB is a clinical stage oncology company developing Modufolin® as a first-line treatment of metastatic colorectal cancer and as a rescue drug after high-dose methotrexate treatment in osteosarcoma. Through a worldwide exclusive license agreement, Isofol Medical holds the rights to commercialise Modufolin® with access to the unique patented production process and the production capabilities of Merck KGaA, Darmstadt, Germany. Isofol Medical AB is traded on the NASDAQ First North Premier. Certified Adviser is FNCA Sweden AB. www.isofol.se

ROTTNEROS INTERIM REPORT JANUARY – JUNE 2017

· Production volume for the second quarter rose by 1% compared with the second quarter of 2016, despite the unplanned shutdown at Vallvik Mill, which entailed a production loss of about 4,500 tonnes. Rottneros Mill set a new quarterly production record once again. · Delivery volume for the second quarter rose by 7% compared with second quarter 2016. · Investments in the Agenda 500 development programme are progressing according to plan, in terms of both cost and increased capacity. · Rottneros Packaging is starting commercial production of fibre trays and will build a new production line. · Shareholders were paid a dividend of SEK 61 million in the second quarter. · Net turnover for the second quarter rose by 14% to SEK 472 million (413). For January-June, net turnover was SEK 944 million (845). · Profit after financial items for the second quarter totalled SEK 62 million (56) and for January-June SEK 118 million (125). Earnings per share for January-June were SEK 0.60 (0.65). · Cash flow from operating activities for the second quarter totalled SEK 53 million (52). · The list price for NBSK pulp over the second quarter was 8% higher in USD and 16% higher in SEK, compared with second quarter 2016. Compared with first quarter 2017, the price level in SEK was 4% higher.  COMMENTS BY THE PRESIDENT: YET ANOTHER QUARTER WITH PRODUCTION OVER 100 THOUSAND TONNES During the second quarter, the underlying trend of rising production rates continued in our mills. Operating profit increased by SEK 5 million despite some negative effects from unplanned items. We can see that the extensive investments within the framework of the Agenda 500 programme are paying off in higher volumes, even though the unplanned shutdown at Vallvik held back growth for the quarter as a whole. We steadfastly continue to take a structured approach to further improve safety and increase capacity utilization, thereby sustainably increasing volumes in our niches. Production rose by 1 per cent in the Group to 101,400 tonnes compared with last year’s second quarter, despite the negative impact of 4.5 per cent from the unplanned shutdown at Vallvik. In May, however, the mill achieved a record volume for a single month at the same time that Rottneros Mill demonstrated the highest production ever for a single quarter. These achievements confirm that we continue to clearly move upwards on the volume curve. Meanwhile, more remains to be done to increase availability and production in the future. Our goal-oriented efforts are also paying off in terms of operating profit, which rose by SEK 5 million compared with the second quarter last year to SEK 62 million, despite the negative impact of certain unplanned items amounting to approximately SEK 5 million and primarily related to the production shutdown at Vallvik. Conflict actions among social partners at the Port of Gothenburg also had a negative impact. Continued stable marketThe market continues to be stable with a good balance between supply and demand and we are cautiously optimistic in the run-up to the third quarter. At the end of the second quarter, the NBSK list price was USD 890, up about 7 per cent. However, new volumes coming from several Nordic players in the second half of the year and 2018 may have a negative impact on the market balance in the future. Our development area, Rottneros Packaging, is now approaching start of construction for the new production line for bio-based food trays in Sunne. Demand in the sustainable packaging solutions market is robust and we are optimistic about the development potential of this new segment. Key new hire at VallvikThe hiring of Michael Berggren as head of Vallvik Mill represents an important step for the further development of the mill. Although we have come a long way, much remains to be done in the development of the organisation. A constant effort to improve skills is crucial for increasing availability at the mills and leveraging our investments. Agenda 500Within the framework for the Agenda 500 programme, the Board of Directors has approved a total of approximately SEK 620 million, of which approximately SEK 460 million has been spent on implementing measures to date and measures for the remaining approximately SEK 160 million will be implemented in 2017 and 2018. The company has good liquidity. As previously announced, we are working with an extended long-term funding strategy, which ensures our ability to carry out the investment programme while changing the capital structure. Planning for the autumn maintenance shutdown is in full swing. Rottneros Mill carries out its shutdown in September and Vallvik plans to stop production in the beginning of the fourth quarter. The estimated cost of these shutdowns is SEK 10 million and SEK 55 million, respectively. We were pleased to see so many shareholders at the Annual General Meeting in Söderhamn. The opportunity to see our new investments at the tour of the mill in Vallvik definitely contributed to the strong attendance. In summary, it is clear that we have established a new level of availability and production volumes at the mills, creating continued growth opportunities, especially in our selected niches. Our focus is to continually optimise the factors we can influence, regardless of external factors. This is particularly important in light of potentially rising costs for our inputs such as wood and electricity in the future. We are becoming better equipped for the future, in terms of both meeting potential challenges and taking advantage of our opportunities. Lennart Eberleh (For full report, please see attached file) This information is information that Rottneros AB is obliged to publish under the EU Market Abuse Regulation and the Securities Market Act. This information was submitted for publication, through the agency of the contact person set out below, on 16 August 2017 at 8:00 a.m. A Swedish and an English version of this report have been drawn up. The Swedish version shall prevail in the event of differences between the two reports. For further information, please contact:Lennart Eberleh, CEO and President, Rottneros AB, +46 270 622 65

Swedbank acquisition of PayEx is approved by competition authorities and Swedish FSA

The market for payment solutions has undergone major changes in recent years by greatly increased on-line purchases and development of invoicing solutions and administrative services. Payment Service Providers (PSP), as PayEx, has been established with the purpose to improve the purchase experience. Through the approval of the acquisition of PayEx, Swedbank has the right prerequisites for continuing to invest in the payments area and continues to develop long term and attractive payment solutions for retail businesses and its customers. PayEx will be a fully owned subsidiary to Swedbank, with headquarters in Visby, Sweden, acting on an open market with both existing and new customers. The company will be consolidated as per 15 August 2017. In 2016 PayEx total operating income amounted to SEK 541m, total operating expenses to SEK 460m and profit before tax to SEK 78m. PayEx total risk exposure amount as per year-end 2016 was SEK 1.7bn. The acquisition will have a minor negative impact on the common equity tier 1 capital ratio of the Swedbank Group of approximately 40bps. For more information, please contact:Josefine Uppling, Group Press Officer, Swedbank, +46 761 14 54 21Gregori Karamouzis, Head of Investor Relations, Swedbank, +46 727 40 63 38 Information about PayExPayEx was founded 1972 by Max Hansson, who has owned the company since then. The company has more than 10 000 customers and approximately 500 employees in Sweden, Norway, Denmark and Finland. PayEx processes more than SEK 250 bn per year in their home markets on their customers´ behalf. PayEx has AAA-rating and is a credit market company, approved by the Swedish FSA. This announcement involves the disclosure of inside informationSwedbank AB (publ) is required to disclose this information pursuant to Regulation (EU) No 596/2014 on market abuse, the Swedish Securities Markets Act (2007:528), the Swedish Financial Instruments Trading Act (1991:980) and the regulatory framework of Nasdaq Stockholm. This information was sent to be published on 16 August, 2017 at 08.00 CET.

INCREASED SALES AND FURTHER FOCUSING OF BUSINESS OPERATION

SECOND QUARTER  · Net sales for the remaining operation totaled SEK 20.2 (18.9) million. · The operating profit for the remaining operation totaled SEK 0.5 (5.3) million. · Profit after tax for the remaining operation totaled SEK 0.2 (5.3) million. · Earnings per share for the remaining operation totaled SEK 0.00 (0.02). · Earnings per share for the total operation totaled SEK 0.00 (0.01). · Cash flow from total operations totaled SEK -1.3 (7.5) million. INTERIM PERIOD   · Net sales for the remaining operation during the interim period totaled SEK 36.8 (39.6) million. · The operating profit/loss for the remaining operation during the interim period totaled SEK -2.2 (12.4) million. · Profit after tax for the remaining operation totaled SEK -3.2 (12.4) million. · Earnings per share for the remaining operation totaled SEK -0.01 (0.04). · Earnings per share for the total operation totaled SEK -0.01 (0.03). · Cash flow from total operations totaled SEK 15.8 (17.5) million. Cash and cash equivalents for the total operation totaled SEK 115.0 (67.4) million at the end of the interim period.  SIGNIFICANT EVENTS   · An agreement was concluded with German company IDENTOS GmbH, which will take over the Mobile Smart Card Solutions business area as of January 1, 2018. · A new security suite was launched with industry-leading software for fingerprint recognition with spoof and liveness detection, as well as standalone anti-spoof products and services. · A licensing agreement was signed with Korean sensor manufacturer Melfas. After the end of the quarter, a licensing agreement was signed with module house O-Film. · Precise BioMatch™ Mobile was integrated into Qualcomm® Fingerprint Sensors, next-generation ultrasound-based fingerprint solutions from Qualcomm. · Seven mobile phones and two smart cards were launched with the company’s fingerprint software. FINANCIAL DATA AND KEY INDICATORS     As a consequence of the fact that the Mobile Smart Card Solutions business area has been classified as a business held for sale, previously reported figures have been converted in order to improve comparability. In order to obtain comparable historical data, previously reported figures have only been adjusted for expenses relating directly to the discontinued business area, which will no longer affect the company’s remaining operation. The resources that were previously allocated to the Mobile Smart Card Solutions business area will be transferred to the Fingerprint Technology business area before the divestment is completed and have therefore not been included in the divested business. Resources are being reinforced in order to meet the market’s demand for increasingly advanced solutions in the field of Fingerprint Technology. The impact of the discontinued operation on the financial position has not been reported separately, as the company does not believe that it is possible to report the impact of the discontinued operation on cash flow. Cash flow is instead reported from the total operation.Unless otherwise specified, reported figures in the interim report relate to the remaining operation. KEY INDICATORS  Amounts in 2017  2016  2017  2016  2016  Rolling SEK thousandunlessotherwisestated    Q2  Q2  Q1-Q2  Q1-Q2  Full 12 year  months Net sales   20,160  18,936  36,777  39,560  83,299  80,516 Net sales 6.5%  175.1%  Neg  282.9%  95.7%  12.2% growth, % Gross 95.0%  97.8%  94.7%  97.9%  98.0%  96.5% margin, % Operating 481  5,344  -2,179  12,402  25,407  10,826 profit/loss Operating 2.4%  28.2%  -5.9%  31.4%  30.5%  13.4% margin, % Operating -1,314  7,462  15,808  17,497  37,658  35,970 cash flow,totaloperationCash and 115,006  67,411  115,006  67,411  135,753  115,006 cashequivalents,totaloperation CEO COMMENTS  It is gratifying that we have increased sales during the quarter, both sequentially and compared with the corresponding period in the previous year. The partnership with Silead has resulted in substantial royalty revenues as Precise BioMatch Mobile has been launched in a number of phone models from one of the world’s biggest manufacturers. We now have royalty revenues from nine customers and continue to broaden the customer base in terms of both different technologies and geographical regions, in order to create good opportunities for growth and to reduce dependence on individual customer partnerships. We are also continuing to invest in development and support resources in Sweden and in the local markets in order to best support our customers.During the quarter we made a strategic decision to divest the loss-making Mobile Smart Card Solutions business area to IDENTOS in order to create a greater focus in the business. This divestment means that we can free up resources in both development and sales in order to strengthen our offering and our opportunities for growth in the field of fingerprint technology.There is currently a surfeit of sensor manufacturers offering capacitive sensors for fingerprint recognition. This has resulted in very tough competition with rapidly increasing demands for smaller sensors, better performance and lower prices, with suppliers that are already established enjoying competitive advantages. This makes it more challenging for many sensor manufacturers to break into the mobile phone manufacturers and capture bigger market shares. It is therefore more difficult to assess the sales volume of our customers during the second half of the year.At the same time we can see that new sensor technologies such as ultrasound and optical sensors are on the rise, which changes the market dynamics and opens the door for new suppliers. Ultrasound and optical sensors make it possible to integrate fingerprint sensors in and under the display, creating new design possibilities and lower product costs. There is a large interest in these kinds of solutions among mobile phone manufacturers. Many of our customers are offering ultrasound or optical sensors, which means that we are well positioned for the upcoming technology shift. We are working together with customers on several test projects, which we expect to result in product launches starting in the first half of 2018 and provide a further boost to our growth. For example, Qualcomm recently launched a new generation of ultrasound sensors and demonstrated the product in a modified version of VIVO XPlay 6 with our Precise BioMatch Mobile fingerprint software.We launched a new security suite during the quarter, offering industry-leading software for fingerprint recognition with the latest developments in spoof and liveness detection, as well as standalone anti-spoof products and services. The software is particularly suitable for optical and ultrasound sensors, and enhances security significantly for fingerprint recognition by identifying fake fingers and thereby combating fraud. The new solutions have generated a high level of interest among our customers and give us a unique position, as we are the only supplier that can offer software-based fingerprint software with spoof and liveness detection.Cards with fingerprint technology are on the rise. We announced two projects during the second quarter. Elan MicroElectronics launched a payment card with fingerprint technology that is to be supplied to premium customers of a South Korean bank. MeReal announced that their V2 biometric smart card will be put into use by Pleinair Casino. It is clear from work with our customers that the card market is developing quickly for both payments and other areas of application. We are involved in a number of card projects and are holding advanced discussions with several players in the card industry.OUTLOOKWe maintain our view on net sales for the remaining operation during 2017 and estimate that it will be on par with the comparable net sales for 2016 (SEK 83.3 million), even though the volume trend among our customers is more difficult to estimate than before. The company continues to expect an operating profit for the full year 2017 for the remaining operation.  PRESENTATION OF THE INTERIM REPORT           In connection with today’s interim report, we issue an invitation to an information event today at 10:00. Please see the last page of the interim report for further information about participation.  This information is information that Precise Biometrics AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 CEST on August 16, 2017.

Biotage – alleged patent infringement settled

Scientific Plastic Products, Inc. (“SPP”) has brought claims for infringement of U.S. Patent Nos. 8,066,875 and 8,070,957, against Biotage et alt. in a civil action entitled Scientific Plastic Products, Inc. v. Biotage AB, et al. (“Defendants”), pending in the United States District Court for the Southern District of California (the “Lawsuit”). The matter has been amicably resolved and the Lawsuit has been dismissed. Defendants have not agreed to any liability and no claim remains pending against Defendants. The terms of settlement are confidential. Contact persons:Torben Jörgensen, CEOTel: 0707-49 05 84, torben.jorgensen@biotage.com This information is information that Biotage AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on August 16, 2017. About Biotage Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and South Korea. Biotage has approx. 300 employees and had sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic. Website: www.biotage.com

FDA accepts Medivir´s IND application for MIV-711, enabling clinical development in the US

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces today that the Investigational New Drug (IND) application for MIV-711 has been accepted and the IND is now open with the FDA (U.S. Food and Drug Administration). “We are very pleased to have received FDA acceptance for our IND. This is a regulatory milestone for MIV-711 and enables clinical development of MIV-711 in the US, in addition to the already completed and ongoing studies in Europe” says Åsa Holmgren, Medivir´s EVP Strategic Regulatory Affairs and Market Access. About MIV-711MIV-711 is being developed to slow or reverse the progressive degeneration of joints affected by osteoarthritis, and is therefore referred to as a Disease Modifying Osteoarthritis Drug (DMOAD). Since there are no DMOADs approved for use currently, the standard of care for osteoarthritis patients is based on changes in life style and the use of analgesics. The long-term use of analgesics by osteoarthritis patients is associated with an increased risk of side effects such as gastrointestinal bleeding and opioid dependency. DMOADs therefore represent a very large and attractive market opportunity. Medivir estimates that the US market alone is greater than USD 6 billion annually for a drug that impacts disease progression, even if its use was restricted just to patient populations with moderate osteoarthritis in weight-bearing joints. For further information, please contact:Ola Burmark, CFO Medivir AB, mobile +46 (0)725-480 580 About MedivirMedivir is a research-based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical needs. Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Episurf Medical reaches milestone of 250 implants

Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by planning of its 250th surgery with the Episealer® implant in the coming weeks. “This milestone is very important for us, and at the same time, it is important to keep in mind that our clinical data is very strong and the patients are truly being helped by our technology. That said, it is obviously very encouraging that we have cut the time between our 50 intervals in half. Increasing our sales is important and this is a clear sign of the fact that the Episealer technology is gaining increased acceptance. This is a good day for Episurf Medical and I want to extend my gratitude to all orthopaedic surgeons, patients and employees“, says Pål Ryfors, CEO Episurf Medical. "It is reassuring to note that the orthopedic profession seems to catch on and note the good clinical results and the very few complications and adopt the Episealer technology. It starts to look as an exponential increase in users and usage of the Episealer device", says Prof. Leif Ryd, Senior Medical Advisor Episurf Medical. For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.35 CET on 16 Augusti 2017.

SOTKAMO SILVER IS IN ADVANCED DISCUSSIONS ABOUT THE FINANCING OF THE SILVER MINE

Sotkamo Silver is in advanced discussions with a large international resources financing institution and the Swedish Export Credit Agency (ECA) for a comprehensive financing package, to fund the Engineering and Process Equipment (EPC) contract with Outotec and enable the mine to reach the production start. The discussions concerning terms and conditions are dependent on the guarantee decision of The Swedish Export Credit Agency (ECA). The discussions do not constitute a commitment or an offer to commit to any transaction or financing. The next step is the guarantee decision of the Board of the ECA. The decisions will be taken earliest on the 23rd August. Outotec provides leading technologies and services for the Sustainable use of Earth’s natural resources. “After the publishing of the Technical Report, the Company is fortunate to have multiple financing discussions going on, which is a market recognition of the quality of the Sotkamo Silver’s project. We are working with several options and are in advanced discussions with the resources financing institution and ECA”, says Dr Timo Lindborg, CEO Sotkamo Silver Stockholm August 16th, 2017 Sotkamo Silver AB (publ) This information is information that Sotkamo Silver AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:45 CEST on August 16th, 2017. Contact personTimo Lindborg, CEO of Sotkamo Silver AB, tel. +358 40 508 3507 The official Stock Exchange Releases are given in Swedish and there may be differences in the translated versions. About Sotkamo Silver AB Sotkamo Silver AB´s business concept is to exploit mineral deposits in the Nordic countries with positive social and environmental benefits. Sotkamo Silver owns mineral deposits, which contain silver and gold in Finland as well as zinc and gold in Norway. The Company’s main development project is the Silver Mine project in the municipality of Sotkamo. Sotkamo Silver applies SveMin’s & FinnMin’s respective rules of reporting for public mining & exploration companies. Sotkamo Silver has chosen to report mineral resources and ore reserves according to the internationally accepted JORC or NI 43-101 code. The company applies International Financial Reporting Standards (IFRS) as approved by the European Union. The ticker symbol is SOSI in NGM Equity in Stockholm and SOSI1 in NASDAQ OMX Helsinki. ISIN-code for Sotkamo Silver shares is SE0001057910. ISIN- code for share warrants series 2016/2017 are SE0008373880 with the ticker symbol SOSI TO4 in NGM Equity and SOSI1EW116 in NASDAQ OMX Helsinki. The number of outstanding warrants are 20,643,198. The Warrant gives the right to subscribe for one (1) share at 4 SEK in August 2017 Legal Entity Identifier (LEI): 213800R2TQW1OZGYDX93 Read more about Sotkamo Silver on www.silver.fi The Company's press releases and financial reports are distributed via Cision Sverige and are available on www.silver.fi

Schulthess Maschinen AG gets ready for the future by upgrading to IFS Applications 9

IFS Applications 9 empowers Schulthess Maschinen AG to cover many of its new requirements without the need for significant customizations. A key feature of IFS Applications 9 is IFS Lobby, which is a personalized interface into the solution appropriate not only to the users’ level and role but also their personal preferences. The modern layered architecture of IFS Application 9 enables Schulthess Maschinen AG to perform updates easily and quickly so that the company can continue to operate on the latest version of the software. Having used IFS Applications for over a decade, the upgrade to IFS Applications 9 will continue to support business critical processes like: finance, sales and support, engineering, production, logistics, service management and maintenance. In addition, Schulthess Maschinen AG will now also utilize IFS Warehouse Data Collection, a mobile solution for automation of inventory management. In a preliminary project, IFS and Schulthess Maschinen AG analyzed the company’s individual customizations of IFS Applications 7 to define which need to be lifted, which are covered by the standard deployment of IFS Applications 9, as well as which were obsolete. This way, the number of customizations Schulthess Maschinen AG will migrate to IFS Applications 9 will be reduced by around half. “We are glad to continue our longstanding and trusted partnership with IFS”, Schulthess Machinen AG CFO, Martin Keller, said. “Upgrading to IFS Applications 9 is a big and important technological step for the digital future of our company. The layered architecture of IFS enables us to run our solution in an ‘evergreen’ mode so that it is continuously up-to-date.” “We’re honored by the continued trust of Schulthess Maschinen AG in IFS”, Guido Zumstein, Managing Director of IFS in Switzerland, added. “It’s not only testament to our future-proof technology but it also confirms our approach to accompany customers as a longstanding partner supporting their successful corporate development with our comprehensive industry expertise.” More information on the IFS solutions for the industrial manufacturing: http://www.ifsworld.com/corp/industries/industrial-manufacturing/

Nordic Nanovector ASA: Invitation to Second Quarter 2017 Results Presentation and Webcast

Oslo, Norway, 16 August 2017 Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics for haematological cancers, will announce its second quarter 2017 results on Wednesday, 23rd of August 2017. A presentation by Nordic Nanovector’s senior management team will take place at 8:30 am CEST at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: BJØRVIKA The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investor Relations/Webcast. The results report and the presentation will be available at www.nordicnanovector.com in the section: Investor Relations/Reports and Presentation/Quarterly Reports/2017 from 7:00 am CEST the same day. For further information, please contact:IR enquiries:Tone Kvåle, Chief Financial OfficerCell: +47 91 51 95 76Email: ir@nordicnanovector.com MediaEnquiriesMark Swallow/David Dible/Marine Perrier (Citigate Dewe Rogerson)Tel: +44 207 638 9571Email: nordicnanovector@citigatedr.co.uk About Nordic Nanovector:Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The company aspires to become a leader in the development of targeted therapies for haematological cancers.Nordic Nanovector’s lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin’s Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024.The Company aims to rapidly develop Betalutin®, alone and in combination with other therapies, for the treatment of major types of NHL, targeting first regulatory submission in relapsed/refractory follicular lymphoma in 1H 2019. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. The Company is also advancing a pipeline of ARCs and other immunotherapies for multiple cancer indications. Further information about the Company can be found at www.nordicnanovector.com

TROAX: INTERIM REPORT JANUARY – JUNE 2017

APRIL – JUNE 2017 · Order intake increased by 30 per cent to 39,8 (30,5) MEUR. Adjusted for acquisition and currency the increase was 17 per cent. · Sales increased 40 per cent to 39,6 (28,3) MEUR. Adjusted for acquisition and currency the increase was 26 per cent. · Operating profit increased to 8,2 (5,1) MEUR. · Operating margin increased to 20,7 (18,0) per cent. · Financial net was -3,4 (-0.9) MEUR of which -2,3 MEUR is related to a one-time cost related to the redemption of the bond. · Profit after tax increased to 3,7 (3,1) MEUR. · Earnings per share was 0,19 (0,16) EUR. JANUARY – JUNE 2017 · Order intake increased by 31 per cent to 78,3 (59,6) MEUR. Adjusted for acquisition and currency the increase was 17 per cent. · Sales increased 38 per cent to 75,9 (55,1) MEUR. Adjusted for acquisition and currency the increase was 22 per cent. · Operating profit increased to 14,8 (9,8) MEUR. · Operating margin increased to 19,5 (17,8) per cent. · Financial net was -4,6 (-1,8) MEUR of which -2,3 MEUR is related to a one-time cost related to the redemption of the bond. · Profit after tax increased to 7,7 (5,9) MEUR. · Earnings per share was 0,39 (0,30) EUR. CEO COMMENTS  Troax has developed well during the second quarter with an organic increase in orders of 17%, which clearly is above the historical growth average. We have received several important orders from customers within, automotive, warehouse and property, which shows that the Troax offering is strong. The newly acquired company in the USA, Folding Guard is following their plans and has a favorable trend in orders received. Our judgment is that the market development during the second Quarter has been positive for the Group. The growth has been especially strong in Continental Europe, and also new Markets have had a positive quarter. In the UK, we have during the second quarter seen some negative effects of a weaker willingness to invest at some customer groups, probably caused by the uncertainty related to Brexit etc. The orderbook at the end of the quarter continues on a good level. The integration work of the acquired company (end of last year), Folding Guard is progressing well. During the second quarter, the Nashville warehouse has been closed and the distribution moved to Chicago. The focus on growth continues to be strong but is not expected to show any bigger impacts until 2018/19. We can again confirm that the acquisition has so far been well received by important customers in the US. We see good opportunities to strengthen the customer base, long term, for both brands in the important market of North America. Sales invoiced increased in the quarter by 40 per cent compared with the same period last year (excluding acquisition and currency the increase is 26 per cent). The progress was positive in all markets. Totally, the Group has increased to an order intake level of approximately 138 MEUR on a rolling 12 month basis (including Folding Guard for the first two quarters of 2017). The result has continued to improve during the quarter, mainly because of good sales volumes and the consequential good capacity utilization in our factories. During last year, we also had some one-time costs related to the inauguration of the new paint line which we do not have this year. The market investments are continuing per plan. This is at a lower level short term, as some internal resources have been dedicated to the integration of our American acquisition. The operating result was 8,2 (5,1) MEUR, which corresponds to a profit margin of 20,7 per cent to be compared with 18,0 per cent last year. It should be noted that the consolidation of Folding Guard decreases the margin in percentage terms. We do however see clear possibilities to increase the margin also for Folding Guard long term. The Net result has also developed in a positive way, and amounts to 3,7 MEUR for the quarter (3,1 MEUR). In this comparison, we must consider that we have had a one-time financing cost of -2,3 MEUR related to the redemption of the bond in order to move over to ordinary bank financing. Barring any other eventualities, this change in the company’s financing structure will improve the finance net by 3,4 MEUR annually from now onwards. The result per share after the first half year is 0,39 EUR to be compared with 0,30 EUR last year. The Working Capital is on a similar level as the previous quarter. Work in Progress is on a continued high level, indicating that some important projects still are under implementation and hence still have not been invoiced.  We have continued with good cash generation from operations during the quarter and the net debt is now 66,5 MEUR and the key figure of our interest-bearing loan in comparison with EBITDA is below our target for the Group. Thomas Widstrand, President and CEO PHONE CONFERENCE Invitation to presentation of the second quarter result:Thomas Widstrand, CEO presents the result on a phone conference on the 16th of August 2017 at 16:00 CET. The conference will be held in English. For more information, please refer to http://www.troax.com/en/news. This information is information that Troax Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014 and the Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person set out above, at 12:30 CET on 16th of August, 2017.

Talkpool Interim report January – June 2017

APR 1st – JUNE 30th 2017 ·Net sales amounted to EUR 3 441 thousand (2 653), a 29.7 percent increase ·EBITDA of EUR 86 thousand (-9) and EBITDA margin of 2.5 percent (-0.3) ·EBIT of EUR 67 thousand (-20) and EBIT margin 2.0 percent (-0.8) ·Loss after tax of EUR -116 thousand (84). ·Cash flow from operating activities amounted to EUR 158 thousand (51) JAN 1st – JUNE 30th 2017 ·Net sales amounted to EUR 6 896 thousand (5 109), a 35.0 percent increase ·EBITDA of EUR -44 thousand (75) and EBITDA margin of -0.6 percent (1.5) ·EBIT of EUR -80 thousand (55) and EBIT margin -1.2 percent (1.1) ·Loss after tax of EUR -305 thousand (-65). ·Cash flow from operating activities amounted to EUR 167 thousand (72) APRIL - JUNE HIGHLIGHTS ·Talkpool acquired LCC Pakistan with 1,000 employees and EBITDA of around EUR 1.5 million ·Talkpool’s Group EBITDA went from an operative loss of EUR -130 thousand in Q1 2017 to a profit of EUR 86 thousand in Q2 2017 ·Talkpool’s new growth-through-M&A Strategy proved successful as the newly acquired companies Camouflage and Technetix contributed significantly to the positive financial development ·European network operators such as Deutsche Telekom, Belgacom, Vodafone and Orange became the fastest growing client segment for TalkPool ·TalkPool became a Deutsche Telekom entrusted partner for FTTH projects in eastern Germany ·Talkpool Mexico’s investments in staff hiring, training and tools paid off as the company reached break even ·Talkpool AG and Sigren Engineering AG were awarded an IoT smart building assignment for real estate in Zürich CEO COMMENTS The positive Q2 report comes as no surprise. The positive trends in terms of revenue, profits and cashflow continue. Talkpool reports an EBITDA profit (of EUR 86 thousand) for the first time since its IPO. The newly acquired companies Camouflage and Technetix are developing well at the same time as Talkpool continues its positive organic development. The revenue growth continues and many of our markets developed well, with additional contracts and increasing orders. In addition to the positive organic development of our business, the newly acquired companies Camouflage and Technetix performed well in Q2. Camouflage almost doubled revenues from Q1 to Q2 and more than six-folded its profit. Camouflage was in the closing phase of an important operation & maintenance contract in June. It is a long term contract, similar to the one in Haiti, with recurring orders and a revenue stream that is valuable for the financial stability and growth of the company. Technetix in Belgium continued with solid revenue in Q2, in line with Q1, and managed to more than double the profit compared to Q1. The positive order trend from European network operators such as Deutsche Telekom, Belgacom, Vodafone and Orange continued in Q2.  Growth through M&A The acquisition of LCC in Pakistan that has 1,000 employees and EBITDA of around EUR 1.5 million for latest financial year, is a significant event in Talkpool’s history and a giant leap in the company’s growth development. After consolidating LCC into the Group, we are expecting to double revenues, improve EBITDA margins and reach a positivestrengthen our operative cashflow. We’re planning to develop LCC Pakistan into the company hub for the Middle East. The LCC acquisition accelerates Talkpool’s transformation into a profitable and fast-growing business that stands on its own feet. We have now achieved the first step in our strategic roadmap and through this we have gained the financial and operational stability to increase the investments in the emerging Internet of Things industry. Growth through M&A has turned out successful with the first two acquisitions of Technetix and Camouflage. In addition to the significant financial contribution those acquisitions also add new knowledge, customer segments and geographical regions to Talkpool Group. The added value will become even more obvious as LCC Pakistan is added to the group. Furthermore, know- how is also being gained by analzying the market and the different acquisition target companies. Based on this success we will continue on our acquisition path for both network services and IoT. Organic growth in many regions Talkpool Mexico had a slow startofin2017 Q1 with very little project activities due to a combination of seasonality and the Trump effect, but in Q2 the market started moving again and Talkpool Mexico’s investments in staff hiring, training and tools started to pay off. Our activities in Germany also continued to gain speed in Q2. Talkpool is now an established provider of broadband network design and project management services to Deutsche Telekom in the big government-sponsored fiber build-out in Germany. The federal government in Germany plans to roll out a gigabit internet service across the country by 2025. The EUR 100 billion project will focus on bandwidth, security and response times. The development, including virtual reality and the internet of things, will bring huge data growth and the need for more bandwidth, reliable real-time transmission and intelligent networks. Haiti and Tanzania continued to deliver stable and reliable revenue and profits and the outlook is good in both countries. Digicel in the Caribbean issued a request for quotation for the operation and maintenance in Haiti and other major markets in the region and Talkpool is very well positioned to extend the contract for the existing region and expand into new areas. IoT Talkpool AG and Sigren Engineering AG were awarded an IoT smart building assignment for real estate in Zürich, Switzerland that hosts a large search engine company and other prime tenants. The project is considered strategically important. The sales of Talkpool´s IoT temperature and humidity sensors continued to develop very well and the new partner contract with Avnet Silica will contribute very positively to this trend. The IoT market has not developed as expected and until now we have not had any major break through although we are well positioned in the market and have many good customer relations and prospects. We will continue investing in in-house R&D and organic growth, in particular in the key verticals Smart Building and Environmental Supervision. Based on the successful acquisitions in the Network Services area we think that growth through M&A is the way forward in the area of IoT as well and Talkpool is looking at interesting targets.  Continuous efforts improve profitability Talkpool managed to generate a net sales growth from EUR 2 653 thousand in Q2 2016 to EUR 3 441 thousand in Q2 2017 which corresponds to a of 29,7 percent increase. The large increase is mainly explained by the acquisition of Camouflage and Technetix, contributing with net sales in profitable niche network services areas of approximately EUR 752 thousand in Q2 2017. In addition to this, the investments made to fuel the growth in Mexico and Germany showed result and revenue continued to steadily increase throughout the quarter. Thanks to reductions in cost of sales, Talkpool increased the gross profit with approximately 25 percent compared to Q1 2017 and 49 percent compared to Q2 2016. The focused and conscious efforts to reduce SG&A costs continued to bear fruit in Q2. In spite of being in the middle of Talkpool’s biggest acquisition ever, we managed to reduce the SG&A costs with another 6.5 percent in Q2 compared to Q1. In Q2 2017 EBITDA turned positive with EUR 86 thousand compared to an EBITDA of EUR -129 thousand in Q1. This is mainly explained by lower costs of sales and SG&A costs. The newly acquired companies, Camouflage and Technetix, even reached gross margins of over 30 percent. Also the previously loss making growth markets Mexico and Germany both left “the red zone” and reached break even at the end of Q2. EBIT for the group in Q2 reached EUR 67 thousand. Although EBITDA and cashflow turned positive in Q2, net earnings remained below zero. The net loss amounted to EUR -116 thousand mainly due to unusually high exchange losses on cash and bank accounts. The cash flow from operating activities was positive despite a negative result for Q2 and the total cash flow for Q2 2017 was positive by EUR 1 322 thousand mainly due to increase in borrowings. Q3 started off well as Camouflage signed the important operation & maintenance contract and Talkpool and its partners were awarded the prestigiuos IoT project for environmental monitoring in West Sweden where Talkpool will have a prominent role. Erik Strömstedt, CEO     FOR FURTHER INFORMATION, PLEASE CONTACT: Erik Strömstedt, CEO Telephone: +41 79 790 60 40     erik.stromstedt@Talkpool.comHanna Rubensson, CFO    Telephone: +46 73 140 48 40   hanna.rubensson@Talkpool.com This information is such information as TalkPool is required to disclose under the EU Market Abuse Regulation and the Securities Market Act. The information was provided by the contact person below for publication on 16 august 2017 at 13:30 CET.THIS IS TALKPOOL Talkpool builds, maintains and improves telecommunication networks globally. Through its cutting-edge technical expertise, long experience and agile business model, Talkpool offers global telecom vendors and operators high-quality services on short notice no matter the location. Moreover, Talkpool is one of few companies with actual solutions and contracts in place in the exciting IoT-market.

Interim Report 1 January – 30 June 2017

3 months ended 30 June 2017 · Local currency sales increased by 11% and Euro sales increased by 12% to €347.6m (€309.6m). · Number of registered actives decreased by 2% to 2.8m. · EBITDA amounted to €47.9m (€40.6m). · Operating margin was 11.7% (9.9%), favourably impacted by 40 bps from currencies, and operating profit was €40.5m (€30.8m).  · Net profit was €19.9m (€18.1m) and diluted EPS €0.35 (€0.32), negatively impacted by a one-off translation reserve loss on exchange rate of around €3m. The tax rate was further unfavorably impacted by approximately 300 bps from withholding tax on extraordinary large intra group dividends during the quarter. · Cash flow from operating activities was €33.9m (€35.8m).  · During the quarter, Oriflame successfully completed a €70m issue of Euro denominated private placement notes bilaterally agreed with an international investor.  · The year to date sales development is approximately 9% in local currency and the development in the third quarter to date is approximately 10% in local currency. 6 months ended 30 June 2017 · Local currency sales increased by 9% and Euro sales increased by 12% to €687.8m (€615.4m). · EBITDA amounted to €88.3m (€68.3m). · Operating margin was 10.2% (8.4%), positively impacted by 60 bps from currencies, and operating profit was €70.3m (€51.9m).  · Net profit was €39.4m (€28.8m) and diluted EPS €0.69 (€0.51).  · Cash flow from operating activities amounted to €32.5m (€57.3m). CEO Magnus Brännström comments“We are pleased to report double-digit growth in both Euro and local currency with healthy profitability improvements and a strong financial position. During the quarter, our strategic priorities continued to serve as important drivers of growth. CIS experienced local currency growth in the quarter, driven by ongoing productivity increases and positive timing. Asia & Turkey and Latin America were affected by fewer trading days and negative timing of catalogues ­– the underlying performance remained strong. The positive sales momentum for the Group has continued into the third quarter, in which Oriflame celebrates its 50th anniversary Gold Conference.”   OtherA Swedish translation is available on www.oriflame.com. Conference call for the financial communityThe Company will host a conference call on Thursday, 17 August 2017 at 9.30 CET. Participant access numbers:SE: +46856642664DK: +4535445576FIN: +358981710492UK: +442030089808NO: +4723500252US: 18558315947The conference call will also be audio web cast in “listen-only” mode through Oriflame’s website: www.oriflame.com or through http://oriflame-ir.creo.se/170817 August 17, 2017 Magnus BrännströmChief Executive Officer For further information, please contact:Magnus Brännström, Chief Executive Officer Tel: +41 798 263 754Gabriel Bennet, Chief Financial Officer Tel: +41 798 263 769Nathalie Redmo, Sr. Manager IR Tel: +41 799 220 173 This information is information that Oriflame Holding AG is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:15 CET on August 17, 2017. Oriflame Holding AGBleicheplatz 3, CH-8200 Schaffhausen, Switzerlandwww.oriflame.comCompany registration no CHE-134.446.883

Autoliv starts collaboration with Seeing Machines to develop Driver Monitoring Systems

According to the National Highway Traffic Safety Administration, in the United States 3,477 people were killed, and 391,000 were injured, in motor vehicle crashes involving distracted drivers in 2015 alone. The American Automobile Association also states that 21% of crashes in which a person was killed involved a drowsy driver. Autoliv and Seeing Machines have started to collaborate to address this issue by developing a state-of-the-art DMS that can detect distracted and drowsy drivers by accurately measuring eye and head position, driver attention and fatigue. The DMS will invoke action when a dangerous situation is detected or imminent. Reliable understanding of driver state will also enable Autoliv development of technologies critical for supporting highly autonomous driving functions, with safe hands-off-wheel operation. Within the collaboration, Autoliv will serve as the Tier 1 supplier to automotive OEMs to produce the driver monitoring systems for future awarded business. "Autoliv and Seeing Machines have teamed up to reduce distracted driver accidents," says Johan Löfvenholm, President, Autoliv Electronics. "We both share a passion for saving more lives, and together, we will create one of the most advanced driver monitoring systems in the world." “The collaboration between Seeing Machines and Autoliv is an excellent fit within our expanding partnership ecosystem” added Mike McAuliffe, CEO of Seeing Machines. “Both companies are technical leaders deeply committed to advancing safer driving through the development and deployment of our advanced DMS technologies for Automotive OEMs”. Inquiries: Thomas Jönsson, Vice President Corporate Communications. Tel: +46 8 587 206 27 About Autoliv Autoliv, Inc. is the worldwide leader in automotive safety systems, and through its subsidiaries develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 80 facilities with 70,000 employees in 27 countries. In addition, the Company has 22 technical centers in ten countries around the world, with 19 test tracks, more than any other automotive safety supplier. Sales in 2016 amounted to about US $10.1 billion. The Company's shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on Nasdaq Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com. About Seeing Machines Seeing Machines, (AIM: SEE) is an industry leader in computer vision based technologies which enable machines to see, understand and assist people. With more than 17 years of deep domain experience, Seeing Machines deploys its proprietary computer vision platform to deliver precision tracking and analysis of heads, faces and eyes. A primary application is Automotive Driver Monitoring Systems (DMS) to detect and help deal with drowsiness, distraction and other cognitive states which is key to the adoption of ADAS and Autonomous Driving as well as our pioneering Guardian Fleet safety product. Seeing Machines' technology has been adopted by global industry leaders across the market spectrum. Seeing Machines is headquartered in Canberra, Australia and currently has offices and people in Melbourne, Tucson, Silicon Valley, Detroit and the UK. For more information visit www.seeingmachines.com. Safe Harbor Statement This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements, including statements regarding the ability of the parties to successfully collaborate, develop and commercialize driver monitoring system technologies, are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update any such statement, except as required by law.

Results from extension study with C21 show safety, tolerability and indicate effects on lipid metabolism

The extension study, initiated in January 2017, was performed on a group of overweight men (BMI 30-35) and with a hip to waist ratio below 0.9 but otherwise healthy. In total 16 volunteers, whereof 8 were given 100 mg C21 and 8 were given placebo during a period of 8 days participated. The aim of the study was to evaluate safety and tolerability of C21 in a group with a potentially compromised metabolic situation and to investigate if markers of metabolic dysfunction could be affected by C21 during the short treatment period.  The results from the study verified that C21 is well tolerated and safe also in this group as there were no serious adverse effects noted or adverse readings from the laboratory analyses for a large number of biomarkers. In addition, the group receiving C21 demonstrated a tendency to lowering of plasma LDL (low density lipoprotein), the harmful form of cholesterol. Further detailed analysis are still ongoing.  “In view of the small size of the study one should be careful to draw far-reaching conclusions but it is encouraging that we with the support of the study results can formulate a hypothesis that C21 can have positive effects on lipid metabolism” says Professor Mika Scheinin, Principle Investigator for the study, University of Turku, Finland.  The outcome adds to the safety profile of C21 and is important for upcoming Phase IIa study where C21 will be tested on patients suffering from Idiopathic pulmonary fibrosis (IPF).   For further information, please contactPer Jansson, CEOM: +46 709 17 47 46 or e-mail: per.jansson@vicorepharma.com  This is information which Vicore Pharma Holding AB is required to disclose under the EU Market Abuse Regulation and the Securities Market Act. The information was provided by the above contact person's auspices, for publication August 17, 2017 at. 08:50 CET.

Ericsson sues Wiko for patent infringement

On August 14, 2017, Ericsson (NASDAQ: ERIC) sued smartphone maker Wiko, in the regional courts of Düsseldorf and Mannheim in Germany, for infringement of patents essential for 2G, 3G and 4G cellular technology, as well as implementation patents. Wiko has been infringing Ericsson’s intellectual property rights for six years without any license or compensation. Ericsson has tried to establish a fair, reasonable, and non-discriminatory (FRAND ) license agreement with Wiko since May 2013, but has not succeeded. As a last resort, Ericsson has decided to exercise its legal rights to enforce its patents against Wiko’s infringing products. Gustav Brismark, Chief Intellectual Property Officer at Ericsson, says: “Global sharing of technology and open standards are the force behind the smartphone revolution and have allowed new entrants, such as Wiko, to quickly build successful businesses. This ICT eco-system only works, however, if all market players respect the basic rules of FRAND licensing. It is unfair for Wiko to benefit from our substantial R&D investment without paying a reasonable license fee for our patented technology. "Our ambition has always been to reach a mutually fair and reasonable license agreement with Wiko, just as we do with all of our licensees.” Ericsson has one of the industry’s strongest intellectual property portfolios, which includes more than 42,000 granted patents worldwide. Ericsson’s patent portfolio covers 2G, 3G and 4G/LTE technologies, and the company plays a key role in the global organizations that are developing standards for 5G technologies. NOTES TO EDITORS Ericsson IPR press kit   Ericsson on FRAND and standards   More information about Ericsson IPR & Licensing   For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on www.ericsson.com.

Trelleborg invests in high-end production for sealing solutions in Denmark

Trelleborg has, through its business area Trelleborg Sealing Solutions, decided to invest in a new state of the art production facility for sealing solutions in Denmark, thus relocating its current manufacturing facility in the country. The move is intended to transform and further expand the current capabilities of the existing facility to demonstrate future manufacturing principles and technologies that enable profitable sales growth. The investment forms part of Trelleborg’s strategy to strengthen positions in attractive market segments. “The Danish operation is one of our most important ones globally, with committed employees and a product and material portfolio that offers high-end solutions to the most demanding of sealing applications. The new production facility will be dedicated to highly automated and lean production lines for the automotive, aerospace and renewable energy industries, contributing to better business and higher technical customer support,” says Claus Barsøe, President of the Trelleborg Sealing Solutions business area. The production will be relocated to a new facility close to the current one in Helsingør, Denmark. Trelleborg will invest a total of approximately SEK 120 M during 2017-2020. The investment for this year is within the previously announced framework for capital expenditures for 2017. It is estimated that production will be able to commence in the new facility at the beginning of 2020.

Holmen’s interim report January–June 2017

Quarter  January–June Full Year     SEKm  2-17  1-17  2-16  2017 2016 2016 Net sales  4 148 4 131  3 937 8 278 7 765 15 513 Operating   profit 525 627  483 1 152 1 063 2 162 excl. items affectingcomparability Operating   profit  525 627  483 1 152 831 1 930 Profit after   tax  394 485  364 880 587 1 424 Earnings per   share, 4.7 5.8  4.3 10.5 7.0 16.9 SEK Operating   margin, % *  12.7 15.2  12.3 13.9 13.7 13.9 Return on   capital 8.5 10.2  7.7 9.4 8.4 8.6 employed, % * Return on   equity, %  7.5 9.2  7.1 8.4 5.7 6.9 Cash flow   before 482 742  478 1 224 1 232 2 320 investments and workingcapital Debt/equity   ratio  0.19 0.16  0.22 0.19 0.22 0.19  *Excluding items affecting comparability of SEK -232 million in 2016. See also page 15. · Operating profit for January–June 2017 was SEK 1 152 million (January–June 2016: SEK 1 063 million, excluding items affecting comparability). The improvement in earnings was due to higher wood product prices, better earnings from forests and the divestiture of the newsprint mill in Madrid. · Compared with the first quarter, operating profit decreased by SEK 102 million to SEK 525 million as a result of a maintenance shutdown within paperboard and seasonally lower hydro power production. · Profit after tax for January–June amounted to SEK 880 million (587), which corresponds to earnings per share of SEK 10.5 (7.0).  ·  Return on capital employed increased to 9.4 (8.4) per cent. · Production of paperboard, paper and wood products has been established at a higher level than previous years and the sales mix has developed well. Cash flow was strong and largely covered the SEK 1 billion dividend that was paid in April. For further information please contact: Henrik Sjölund, President and CEO, tel. +46 8 666 21 05 Anders Jernhall, EVP and CFO, tel.  +46 8 666 21 22Stina Sandell, Director of Sustainability and Communications, tel +46 739 86 51 12 This information is information that Holmen AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on 17 August 2017 at 12.45 CET.

Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527

Seattle, WA, and Lund, Sweden – August 17, 2017 – Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the companies have initiated CMC activities for the manufacturing of clinical material in preparation for a future investigational new drug (IND) submission for the bispecific immuno-oncology antibody ALG.APV-527. ALG.APV-527 was the subject of a collaboration agreement announced by the companies in July 2017 . It targets the co-stimulatory receptor 4-1BB and an undisclosed tumor antigen that directs the immune activation to the tumor area. 4-1BB is known to enhance the immune response to cancer through activation of tumor-specific T cells and is believed to be a promising target for new immunotherapeutic approaches. The bispecific antibody candidate could potentially have utility in the treatment of a broad spectrum of cancers over-expressing the tumor antigen, including breast, cervical, non-small-cell-lung, prostate, renal, gastric, colorectal and bladder cancers. “With CMC and IND enabling activities underway, our partnership with Aptevo is moving ahead rapidly”, said Per Norlén, Chief Executive Officer of Alligator Bioscience. “Having worked collaboratively to design and engineer ALG.APV-527, we are pleased to now announce its advancement into preclinical development. This bispecific antibody brings tumor directed immunotherapy to the next level. By making the immune activation dependent on binding to a tumor antigen we have created a candidate drug with potential for improved efficacy and fewer side effects.” “The timely progress we are making underscores our respective companies’ expertise in bispecific antibody engineering and we are very excited to begin the next phase of development of ALG.APV-527 and further demonstrate the elegance of our ADAPTIR technology platform”, said Marvin L. White, President and Chief Executive Officer of Aptevo.  “The robust and flexible nature of our ADAPTIR platform permits the development of bispecific antibodies with different mechanisms of immune system engagement.  Because ADAPTIR bispecifics are based on an IgG backbone, they have excellent stability and manufacturing characteristics, with traditional monoclonal antibody-like manufacturing properties – a key differentiator from other bispecific constructs.  As an emerging class of new therapeutics, bispecific antibodies may offer important technological advancements over traditional monoclonal antibodies, including the potential for more precise targeted therapy through enhanced functionality, potency and efficacy.  We look forward to advancing ALG.APV-527 towards IND submission and to further validating the utility of our ADAPTIR protein therapeutic platform.” For further information:Alligator BioscienceCecilia Hofvander, Director Investor Relations & CommunicationsE-mail: cecilia.hofvander@alligatorbioscience.com Aptevo TherapeuticsStacey Jurchison, Sr. Director, Investor Relations and Corporate CommunicationsPhone: +1 206-859-6628E-mail: JurchisonS@apvo.com This information is information that Alligator Bioscience AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 01:00 p.m. CET on 17 August 2017. About Aptevo Therapeutics Inc.Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on novel oncology and hematology therapeutics to meaningfully improve patients’ lives.  The Company has four commercial products – IXINITY®, WinRho®, HepaGam B®and VARIZIG®and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated, bispecific antibodies with unique mechanisms of action.  Aptevo’s primary focus is immuno-oncology, with two ADAPTIR candidates currently in clinical development and a broad portfolio of bispecific immunotherapies in preclinical development.  For more information, please visit www.aptevotherapeutics.com. About Alligator BioscienceAlligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes lead clinical and pre-clinical product candidates (ADC-1013, ATOR-1015, ATOR-1017, and ALG.APV-527) and novel research candidates. ADC-1013 is licensed to Janssen Biotech, Inc., part of J&J, for development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 45 employees. For more information, please visit www.alligatorbioscience.com . Safe Harbor StatementThis press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including, without limitation, statements regarding Aptevo’s outlook, financial performance or financial condition, our technology and related pipeline, collaboration and partnership opportunities, commercial portfolio, Aptevo’s future growth rates, Aptevo’s ability to timely manufacture its products, and any other statements containing the words “believes,” “expects,” “anticipates,” “intends,” “plans,” “forecasts,” “estimates,” “will” and similar expressions are forward-looking statements. These forward-looking statements are based on Aptevo’s current intentions, beliefs and expectations regarding future events. Aptevo cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from Aptevo’s expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Aptevo does not undertake to update any forward-looking statement to reflect new information, events or circumstances. There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including possible negative effects on our business operations, assets or financial results as a result of the separation; a deterioration in our business or prospects; the ability of our contractors and suppliers to supply product and materials;  our ability and the ability of our contractors and suppliers to maintain compliance with cGMP and other regulatory obligations; the results of regulatory inspections; adverse developments in our customer-base or markets and our ability to retain patients; adverse developments in the U.S. or global capital markets, credit markets or economies generally; and changes in regulatory, social and political conditions. Additional risks and factors that may affect results are set forth in our filings with the Securities and Exchange Commission, including Aptevo’s most recent Annual Report on Form 10-K, as filed on March 15, 2017, and our subsequent reports on Form 10-Q and current reports on Form 8-K. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement.

Prominent Italian Tomato Grower Gandini Antonio S.S. Selects Heliospectra LED Lighting Solutions

The order includes Heliospectra’s new E50 series lighting solution. A 500 Watt, durable industrial standard high voltage LED lighting solution, developed to complement Heliospectra’s commercial product portfolio. The E50 series significantly reduces energy and utility costs when compared to traditional high pressure sodium (HPS) lights often used in controlled environment agriculture. “We are now starting to reap the rewards of our increased focus working with commercial producers in the food industry, as well as building strong partnerships with well-known local resellers. By introducing the high-voltage E50 solution we are able to serve a segment we haven’t been able to serve so far. Commercial growers, like Gandini Antonio, recognize the value and business advantages of upgrading to LED technology,” said Ali Ahmadian, CEO of Heliospectra.   The installation will be the first installation of the E50 series in Europe. Delivery will take place during the beginning of Q4 and be visible in the accounts in Q3 and Q4.  About Ageon S.r.l. Ageon is a society located in Cuneo (Piemonte, Italy). Since its foundation, in 1993, Ageon has been involved in the Covered Agriculture Market. Its' vision is to be a “solution provider” for its' Customer, in order to establish a strong partnership and get the best possible results from production. Ageon offers a wide range of products and an affective consultancy service for cultivation in controlled environments. For more information please visit www.ageon.it  - 0039 (0)171 348114 Join the Heliospectra conversation:  ●      Read more at www.heliospectra.com/blog  ●      Follow @Heliospectra  on Twitter ●      Like Heliospectra on Facebook at facebook.com/heliospectra 

Profitable growth and high level of ordersreceived

April – June 2017 ·  Operative net sales SEK 12,813 million (12,781) ·  Operative operating profit SEK 631 million (624) ·  Operative operating margin 4.9 percent (4.9) ·  Pre-tax profit SEK 623 million (609) ·  Earnings per share SEK 1.80 (1.74) ·  Orders received SEK 12,156 million (10,165) ·  Cash flow before financing SEK -1,105 million (6) January – June 2017 ·  Operative net sales SEK 23,909 million (21,473) ·  Operative operating profit SEK 947 million (812) ·  Operative operating margin 4.0 percent (3.8) ·  Pre-tax profit SEK 934 million (755) ·  Earnings per share SEK 2.74 (2.16) ·  Orders received SEK 23,270 million (22,051) ·  Order backlog SEK 37,313 million (33,457) ·  Cash flow before financing SEK 683 million (916) ·  Net debt SEK 2,707 million (3,154) ·  Equity/assets ratio 29.3 percent (27.5)   “Peab’s order situation has been consistently growing for some time which has contributed to higher net sales and a better result for the first half-year 2017. This high level of orders together with select investments in Project Development and Industry create stable conditions for the future”, says Peab’s CEO Jesper Göransson. This information is information that Peab AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at August 18, 2017, 08:00 a.m. CET.For further information, please contact: Jesper Göransson, CEO +46 431 89338 Charlotte Hagö, CIO +46 725 334545

Medivir licenses exclusive rights to MIV-802 for Greater China to Ascletis

Stockholm, Sweden and Hangzhou, China— Medivir AB (Nasdaq Stockholm: MVIR) and Ascletis today announce that Ascletis has licensed the exclusive rights to develop, manufacture and commercialize Medivir’s nucleotide polymerase inhibitor for hepatitis C, MIV-802 (Ascletis code: ASC21), in Greater China.Under the terms of the agreement, Medivir received an upfront payment, and is entitled to receive milestones based on successful development through commercial launch and tiered royalties on net sales of MIV-802 containing products. Ascletis will fund clinical development, manufacturing and commercialization of MIV-802 in Greater China.“We are pleased to have Ascletis as a partner with their track record in advancing development of pharmaceuticals in Greater China and their portfolio of antivirals with which to create a combination drug against hepatitis C” said Christine Lind, CEO of Medivir.“Ascletis has filed an NDA in China for its first HCV NS3/4A medicine, danoprevir, at the end of 2016 and has an HCV NS5A inhibitor in the late stage clinical development. By acquiring MIV-802, a nucleotide NS5B inhibitor, Asceltis is committed to treating, eventually eliminating, hepatitis C in greater China with its multiple leading antiviral combinations including MIV-802,” said Dr. Jinzi J. Wu, CEO of Ascletis.For further information, please contact:Ola Burmark, CFO Medivir AB, mobile: +46 (0) 725 480 580Jianjiong Wang, Associate Director, Corporate Affairs, mobile: +86 181 0650 1929. Email: pr@ascletis.comAbout MIV-802MIV-802 is a potent, pangenotypic nucleotide inhibitor of the HCV NS5B polymerase. Hepatitis C treatments comprise combinations of pharmaceuticals with different antiviral mechanisms. Preclinical data indicate that MIV-802 can be used effectively in combination with other classes of antiviral agents for the treatment of HCV, including protease inhibitors, non-nucleoside NS5B inhibitors, and NS5A inhibitors.About MedivirMedivir is a research-based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical needs. Medivir is listed on the Nasdaq Stockholm Mid Cap List.About AscletisAscletis is a leading biotechnology company dedicated to discovering, developing and commercializing new treatments for liver diseases. Ascletis has assembled an entrepreneurial management and senior scientific team with a track record of successful pharmaceutical discovery and development at major global pharmaceutical companies. To date the company has added four late-stage candidates to its product portfolio: Danoprevir (ASC08), an NDA-filed HCV protease inhibitor, licensed from Roche; Ravidasvir (ASC16), phase II completed HCV NS5A inhibitor, licensed from Presidio Pharmaceuticals; ASC06, a clinical stage, first-in-class, RNAi therapeutic for the treatment of liver cancers, licensed from Alnylam Pharmaceuticals; and ASC09, a phase IIa completed HIV protease inhibitor, licensed from Janssen, a Johnson & Johnson company.For more information, please visit www.ascletis.com or www.ascletis.com.cn

INTERIM REPORT 1 APRIL – 30 JUNE, 2017

Second quarter 2017, compared to 2016, Group » Group net sales increased by 33% to SEK 622,897 (469,380) » Other operating income including capitalized development expenditure amounted to SEK 607,140 (381,298) » Loss before tax amounted to SEK –12,990,707 (–16,473,988) » Earnings per share (weighted average) amounted to SEK –0.45 (–1.03) Significant events during the second quarter   » Episurf Medical announced that the 50th implantation in Germany of the Episealer® knee implant was performed » Episurf Medical obtained further granted patents in Australia, US and Europe » Episurf Medical strengthened the company’s management group » Episurf Medical reached milestone of 200 implants » Episurf Medical continued its communication with the US Food and Drug Administration (FDA) » Episurf Medical’s Board named Pål Ryfors new CEO and appointed Veronica Wallin as new CFO » Episurf Medical appointed Dr Michael Manley Special Advisor for the US strategy Significant events after the second quarter » Dennis D. Stripe re-assumed the position as non-executive chairman of the board » Case-report with clinical data of Episealer® patient was published » Another preclinical paper on the Episealer® Implant published » Episurf Medical became an approved supplier to Spire Healthcare, one of the UK’s largest Independ­ent hospital providers » Episurf Medical reported a brief clinical update » Management group changes in Episurf Medical were announced » Episurf Medical reached milestone of 250 implants For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on 18 August 2017.

Medivir initiates clinical study of birinapant in combination with KEYTRUDA® (pembrolizumab) in patients with treatment-refractory solid tumours

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the first patient has been enrolled in the company’s phase I/II study of birinapant in combination with the anti-PD-1 therapy KEYTRUDA® (pembrolizumab), which is marketed by MSD (known as Merck & Co., Inc, Kenilworth, NJ, USA in the US and Canada). The objectives of the study are to evaluate the safety, tolerability and preliminary efficacy of this combination in patients with treatment-resistant solid tumours.About the studyThe multicentre, single arm, open label study, which is primarily being run in the US, will be conducted in two parts. In the initial dose escalation (phase I) part of the study, the objective is to identify the recommended phase II dose of birinapant for use in combination with KEYTRUDA®. This is to be achieved by administering increasing doses of birinapant in combination with the approved dose of KEYTRUDA® to cohorts of up to 6 patients with refractory solid tumours.Once the recommended phase II dose has been identified, the second part of the study will begin. The primary objective of the phase II part is to evaluate the safety and tolerability of birinapant in combination with KEYTRUDA® in several cohorts. Each cohort will be made up of patients with the same treatment refractory tumour type. An important secondary objective in the phase II part is the preliminary evaluation of the efficacy of the combination in each of the cohorts.Under the terms of the agreement between Medivir and MSD (through a subsidiary), MSD will provide KEYTRUDA® for this study at no cost to Medivir. Medivir retains full rights to birinapant. Additional details were not disclosed.“The approval of immune check-point inhibitors constituted a remarkable leap forward for many cancer patients, but there still remains a substantial opportunity to improve outcomes. Recent preclinical data have provided a strong scientific rationale for combining birinapant with immune checkpoint inhibitors such as KEYTRUDA®. We are therefore very pleased to enrol the first patient in this combination study, which will allow us to determine its safety and tolerability, as well as its potential efficacy, in patients with solid tumours who have no further treatment options,” said John Öhd, Chief Medical Officer at Medivir.About birinapantBirinapant is a parenterally administered bivalent peptidomimetic of the SMAC protein (Second Mitochondria-derived Activator of Caspases) and is therefore known as a SMAC mimetic compound. Birinapant binds to and degrades Inhibitors of Apoptosis Proteins (IAPs), which both enables apoptosis (programmed cell death) in tumour cells, and activates the immune system, enhancing its attack on the tumour. Birinapant has the potential, through its actions on tumour cells and cells of the immune system, to improve the treatment of several types of cancer when used in combination with other drugs including checkpoint inhibitors and DNA damaging agents.For further information, please contact:Ola Burmark, CFO Medivir AB, mobile: +46 (0) 725 480 580John Öhd, CMO Medivir AB, mobile +46 (0) 725 296 200Medivir AB is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on 18 August 2017.About MedivirMedivir is a research-based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet the unmet medical needs of cancer patients. Medivir is listed on the Nasdaq Stockholm Mid Cap List.KEYTRUDA® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA